PATH: Form 990, tax year 2013
View the entire original 990 at ProPublica ↗
- Organization
- PATH (EIN 91-1157127)
- Tax period
- 2013-01-01 to 2013-12-31
- Filed
- 2014-11-14
- IRS object ID
- 201433189349308503
- Schema version
- 2013v3.0
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule C
- Schedule D
- Schedule F
- Schedule I
- Schedule J
- Schedule M
- Schedule O
- Schedule R
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2014-11-14T15:59:49-06:00 | ReturnTs |
| Tax Period End | 2013-12-31 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Firm EIN | 521392008 | PreparerFirmEIN |
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | GELMAN ROSENBERG & FREEDMAN | BusinessNameLine1 |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 4550 MONTGOMERY AVE SUITE 650N | AddressLine1 |
| City | BETHESDA | City |
| State | MD | State |
| ZIP Code | 208142930 | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2013-01-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 911157127 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | PATH | BusinessNameLine1 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Control | PATH | BusinessNameControlTxt |
| Phone | 2062853500 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 2201 WESTLAKE AVENUE NO 200 | AddressLine1 |
| City | SEATTLE | City |
| State | WA | State |
| ZIP Code | 98121 | ZIPCode |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | OLIVIA POLIUS | PersonNm |
| Person Title | CFO | PersonTitleTxt |
| Phone | 2062853500 | PhoneNum |
| Signature | 2014-11-14 | SignatureDt |
| Discuss With Paid Preparer | Yes (1) | DiscussWithPaidPreparerInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Phone | 3019519090 | PhoneNum |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2013 | TaxYr |
| Build TS | 2015-11-30 17:44:51Z | BuildTS |
Form 990 IRS990
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | STEVE DAVIS | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 2201 WESTLAKE AVENUE NO 200 | AddressLine1 |
| City | SEATTLE | City |
| State | WA | State |
| ZIP Code | 98121 | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $326,602,394 | GrossReceiptsAmt |
| Group Return For Affiliates | 0 | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | WWW.PATH.ORG | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 1981 | FormationYr |
| Legal Domicile State | WA | LegalDomicileStateCd |
| Activity Or Mission | SEE PART III, LINE 1. | ActivityOrMissionDesc |
| Voting Members Governing Body | 12 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 12 | VotingMembersIndependentCnt |
| Total Employee | 694 | TotalEmployeeCnt |
| Total Volunteers | 0 | TotalVolunteersCnt |
| Total Gross UBI | $0 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $0 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $171,536,869 | PYContributionsGrantsAmt |
| CY Contributions Grants | $260,656,932 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $27,292 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $3,946 | CYProgramServiceRevenueAmt |
| PY Investment Income | $2,677,407 | PYInvestmentIncomeAmt |
| CY Investment Income | $2,050,396 | CYInvestmentIncomeAmt |
| PY Other Revenue | $739,627 | PYOtherRevenueAmt |
| CY Other Revenue | $2,433,300 | CYOtherRevenueAmt |
| PY Total Revenue | $174,981,195 | PYTotalRevenueAmt |
| CY Total Revenue | $265,144,574 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $70,398,415 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $72,704,584 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $90,685,304 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $101,626,168 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $0 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $2,924,838 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $113,262,887 | PYOtherExpensesAmt |
| CY Other Expenses | $111,371,191 | CYOtherExpensesAmt |
| PY Total Expenses | $274,346,606 | PYTotalExpensesAmt |
| CY Total Expenses | $285,701,943 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | -$99,365,411 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | -$20,557,369 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $507,730,565 | TotalAssetsBOYAmt |
| Total Assets EOY | $485,822,280 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $59,191,414 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $57,067,664 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $448,539,151 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $428,754,616 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | OUR MISSION IS TO IMPROVE THE HEALTH OF PEOPLE AROUND THE WORLD BY ADVANCING TECHNOLOGIES, STRENGTHENING SYSTEMS, AND ENCOURAGING HEALTHY BEHAVIORS. (CONTINUED ON SCHEDULE O) PATH IS THE LEADER IN GLOBAL HEALTH INNOVATION. AN INTERNATIONAL NONPROFIT ORGANIZATION, WE SAVE LIVES AND IMPROVE HEALTH, ESPECIALLY AMONG WOMEN AND CHILDREN. WE ACCELERATE INNOVATION ACROSS FIVE PLATFORMS-VACCINES, DRUGS, DIAGNOSTICS, DEVICES, AND SYSTEM AND SERVICE INNOVATIONS-THAT HARNESS OUR ENTREPRENEURIAL INSIGHT, SCIENTIFIC AND PUBLIC HEALTH EXPERTISE, AND PASSION FOR HEALTH EQUITY. BY MOBILIZING PARTNERS AROUND THE WORLD, WE TAKE INNOVATION TO SCALE, WORKING ALONGSIDE COUNTRIES PRIMARILY IN AFRICA AND ASIA TO TACKLE THEIR GREATEST HEALTH NEEDS. TOGETHER, WE DELIVER MEASURABLE RESULTS THAT DISRUPT THE CYCLE OF POOR HEALTH. | MissionDesc |
| Significant New Program Srvc | 0 | SignificantNewProgramSrvcInd |
| Significant Change | 0 | SignificantChangeInd |
| Expense | $105,218,480 | ExpenseAmt |
| Grant | $37,563,343 | GrantAmt |
| Revenue | $1,762 | RevenueAmt |
| Desc | PRODUCT DEVELOPMENT: PATH DEVELOPS AND INTRODUCES APPROPRIATE, AFFORDABLE TECHNOLOGIES TO ADDRESS URGENT HEALTH CHALLENGES, PARTICULARLY IN LOW-RESOURCE SETTINGS. THESE TECHNOLOGIES INCLUDE VACCINES, DRUGS, DIAGNOSTICS, DEVICES, AND DIGITAL HEALTH SOLUTIONS. DESIGNED WITH INPUT FROM USERS AND RECIPIENTS, OUR LOW-COST, EVIDENCE-BASED PRODUCTS ARE TRANSFORMING HEALTH WORLDWIDE. PATH ACCELERATES THE DEVELOPMENT AND DELIVERY OF RELIABLE, LOW-COST VACCINES AGAINST LIFE-THREATENING DISEASES. OUR PORTFOLIO INCLUDES VACCINES FOR DIARRHEAL DISEASE, INFLUENZA, JAPANESE ENCEPHALITIS, MALARIA, MENINGITIS, PNEUMOCOCCAL DISEASE, POLIO, AND MORE, AS WELL AS INNOVATIVE DELIVERY STRATEGIES TO ENSURE VACCINES REACH THE SETTINGS WHERE THEY ARE NEEDED MOST. IN 2013, WE SAW SIGNIFICANT SUCCESS IN OUR EFFORTS TO BRING VACCINES TO MORE COMMUNITIES, ADVANCE NEW VACCINE CANDIDATES, AND STRENGTHEN SUPPLY CHAINS AND SYSTEMS.THE WORLD HEALTH ORGANIZATION (WHO) GRANTED ITS STAMP OF APPROVAL, CALLED PREQUALIFICATION, TO A PATH-ADVANCED VACCINE TO FIGHT JAPANESE ENCEPHALITIS. PATH HAD IDENTIFIED THE VACCINE, HELPED THE CHINESE MANUFACTURER MEET REGULATORY STANDARDS, SECURED AN AFFORDABLE PUBLIC-SECTOR PRICE, AND PREPARED COUNTRIES TO INTRODUCE IT. WE ARE WORKING WITH PARTNERS TO ROLL OUT THE VACCINE ACROSS ASIA.IN 2013, ANOTHER 50 MILLION AFRICANS WERE VACCINATED WITH THE MENAFRIVAC VACCINE, WHICH WAS DEVELOPED BY PATH, WHO, AND SERUM INSTITUTE OF INDIA LTD. TO PROTECT AGAINST DEADLY MENINGITIS A. NO CASES OF MENINGITIS A HAVE BEEN REPORTED AMONG THE 153 MILLION AFRICANS VACCINATED SINCE 2010. A STUDY REPORTED IN 2013 FOUND THAT THE VACCINE IS HAVING A DRAMATIC IMPACT ON MENINGITIS: THE INCIDENCE OF ALL FORMS OF THE DISEASE DROPPED BY 94 PERCENT FOLLOWING A MASS IMMUNIZATION CAMPAIGN IN CHAD.PATH ALSO HELPED TO ADVANCE AN AFFORDABLE NEW VACCINE AGAINST THE MOST LETHAL FORM OF DIARRHEA. ROTAVAC REDUCES SEVERE ROTAVIRUS DIARRHEA BY 56 PERCENT IN THE FIRST YEAR OF LIFE AND AT A FRACTION OF THE PRICE OF CURRENTLY AVAILABLE VACCINES. IT HAS NOW BEEN LICENSED BY THE GOVERNMENT OF INDIA. IN ADDITION, PATH HELPED INTRODUCE CURRENTLY AVAILABLE ROTAVIRUS VACCINES TO SEVEN COUNTRIES IN 2013 THROUGH ADVOCACY AND COMMUNICATIONS SUPPORT.PATH CONTINUED TO COLLABORATE WITH GLAXOSMITHKLINE AND OTHERS IN THE FINAL PHASE OF CLINICAL TRIALS OF A VACCINE SHOWN TO HELP PROTECT YOUNG CHILDREN AGAINST THE DEADLIEST MALARIA PARASITE. A PHASE 3 TRIAL FOUND THAT THE VACCINE CANDIDATE, RTS,S, CONTINUED TO PROVIDE MODEST PROTECTION FROM CLINICAL MALARIA FOR INFANTS AND TODDLERS UP TO 18 MONTHS AFTER VACCINATION. PATH'S DRUG WORK ALSO ACHIEVED GAINS IN 2013. PATH DEVELOPS AND INTRODUCES AFFORDABLE DRUGS FOR DISEASES THAT DISPROPORTIONATELY AFFECT PEOPLE IN LOW-INCOME COUNTRIES, INCLUDING DRUGS TO TREAT OR PREVENT DIARRHEA, HIV, MALARIA, AND NEWBORN INFECTIONS. THANKS TO A GLOBAL PARTNERSHIP CONVENED BY PATH THAT DEVELOPED A SEMISYNTHETIC FORM OF ARTEMISININ, MILLIONS MORE PEOPLE WILL BENEFIT FROM THE GOLD-STANDARD MALARIA TREATMENT. THE LAUNCH OF INDUSTRIAL-SCALE PRODUCTION OF SEMISYNTHETIC ARTEMISININ AND WHO PREQUALIFICATION IN 2013 CAPPED A NINE-YEAR EFFORT. UP TO 60 METRIC TONS CAN BE PRODUCED EACH YEAR, WHICH IS ENOUGH TO MEET ONE-THIRD OF THE TOTAL GLOBAL NEED.PATH SAW RESULTS IN OUR INTERNATIONAL EFFORT TO ADAPT A PROVEN ANTISEPTIC, CALLED CHLORHEXIDINE, INTO A NEW FORMULATION FOR USE ON NEWLY CUT UMBILICAL CORDS. AN ESTIMATED 300,000 BABIES COULD BE SAVED EACH YEAR AT A COST OF LESS THAN 50 CENTS A DOSE. IN 2013, WHO ENDORSED THE PRODUCT. IMPLEMENTATION IS UNDER WAY IN 16 COUNTRIES. PATH CONTINUED ITS WORK TO DEVELOP AND INTRODUCE FAST, ACCURATE DIAGNOSTIC TECHNOLOGIES TO DETECT AND TRACK SUCH DISEASES AS CERVICAL CANCER, DIABETES, HIV, MALARIA, NEGLECTED TROPICAL DISEASES, AND TUBERCULOSIS (TB).WE DEVELOPED A NEW DIAGNOSTIC TOOL TO ACCELERATE EFFORTS TO ELIMINATE RIVER BLINDNESS, OR ONCHOCERCIASIS, A LEADING CAUSE OF PREVENTABLE BLINDNESS IN AFRICA. PATH'S DIAGNOSTIC IS THE ONLY ANTIBODY TEST FOR THE DETECTION OF RIVER BLINDNESS TAILORED FOR USE IN THE RURAL AND REMOTE SETTINGS WHERE PEOPLE ARE MOST AFFECTED. IN 2013, WE TRANSFERRED THE TECHNOLOGY TO A SOUTH KOREAN MANUFACTURER, AND WE ARE WORKING TOGETHER TO BRING THE TEST TO MARKET.PATH ALSO WORKS WITH THE PEOPLE WE SERVE TO DEVELOP, ADAPT, AND INTRODUCE HEALTH DEVICES THAT IMPROVE MATERNAL, REPRODUCTIVE, AND NEWBORN HEALTH; NUTRITION; AND WATER AND SANITATION.A KEY 2013 FOCUS WAS INCREASING CONTRACEPTIVE OPTIONS FOR THE 222 MILLION WOMEN WORLDWIDE WHO WANT TO AVOID PREGNANCY BUT ARE NOT USING MODERN CONTRACEPTION. THE SILCS DIAPHRAGM-A ONE-SIZE-FITS-MOST CONTRACEPTIVE DEVICE-WENT ON SALE IN SIX EUROPEAN COUNTRIES IN 2013. IT IS THE FIRST NEW CERVICAL BARRIER METHOD TO REACH THE MARKET IN MORE THAN A DECADE. PATH IS NOW ASSESSING HOW TO INTRODUCE THE DEVICE IN LOW-RESOURCE SETTINGS, INCLUDING INDIA, SOUTH AFRICA, AND UGANDA.PATH AND OUR PARTNERS ALSO DESIGNED THE WOMAN'S CONDOM, WHICH PROTECTS WOMEN FROM BOTH PREGNANCY AND SEXUALLY TRANSMITTED INFECTIONS, INCLUDING HIV. THE WOMAN'S CONDOM WAS APPROVED FOR SALE IN SOUTH AFRICA IN 2013. WE BUILT DEMAND FOR FEMALE CONDOMS OVERALL THROUGH CAMPAIGNS SUCH AS AN INTERNATIONAL FILM CONTEST, WITH WINNING FILMS SCREENED IN MORE THAN TEN COUNTRIES.FINALLY, OUR DIGITAL HEALTH SOLUTIONS GROUP (FORMERLY HEALTH MANAGEMENT INFORMATION SYSTEMS) PROVIDED INFORMATION AND COMMUNICATION TECHNOLOGY PRODUCTS AND SERVICES THAT ADDRESS THE SPECIFIC HEALTH NEEDS OF PROGRAMS AND COUNTRIES. AN EXAMPLE OF THIS WORK IS THE BETTER IMMUNIZATION DATA (BID) INITIATIVE, WHICH SUPPORTS AFRICAN COUNTRIES INTERESTED IN IMPROVING THEIR HEALTH INFORMATION SYSTEM PRODUCTS, POLICIES, AND PRACTICES AROUND DATA QUALITY, COLLECTION, AND USE IN ORDER TO ENABLE EVIDENCE-BASED DECISION-MAKING. | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $74,487,133 | ExpenseAmt |
| Grant | $22,727,162 | GrantAmt |
| Desc | INTERNATIONAL DEVELOPMENT: PATH'S ON-THE-GROUND EXPERIENCE ALLOWS US TO APPLY TAILOR-MADE SOLUTIONS TO URGENT HEALTH NEEDS IN THE COMMUNITIES WE SERVE. PATH COLLABORATES WITH COUNTRY PARTNERS TO IMPLEMENT AN ARRAY OF INNOVATIONS THAT STRENGTHEN HEALTH SYSTEMS, ENCOURAGE HEALTHIER BEHAVIORS, AND INCREASE ACCESS TO AFFORDABLE SOLUTIONS. IN 2013, OUR INTERNATIONAL DEVELOPMENT PORTFOLIO SUPPORTED OFFICES IN 22 COUNTRIES. THIS WORK RANGED FROM SMALL-SCALE PILOTS OF INNOVATIVE SOLUTIONS FOR LOCAL PROBLEMS TO THE LARGEST INTEGRATED HEALTH PROJECT IN EAST AFRICA.THROUGH THE PATH-LED APHIAPLUS WESTERN KENYA PROJECT, WE ARE IMPLEMENTING INTEGRATED STRATEGIES TO TACKLE THE REGION'S GREATEST HEALTH THREATS. IN 2013, WE TRAINED 5,600 COMMUNITY HEALTH WORKERS TO PROVIDE HEALTH EDUCATION AND SUPPORT, ESTABLISHED A COMMUNITY-BASED MOTORCYCLE AMBULANCE SERVICE FOR WOMEN IN LABOR, AND DEVISED A COMPREHENSIVE MALARIA STRATEGY FOR THE REGION. IN ALL, WE REACHED MORE THAN 3.7 MILLION KENYANS IN 2013 WITH INTEGRATED SERVICES FOR HIV/AIDS, MALARIA, MATERNAL AND CHILD HEALTH, AND TB. IN VIETNAM, WE ARE WORKING WITH LOCAL VACCINE MANUFACTURERS TO PRODUCE AND TEST SEASONAL AND AVIAN INFLUENZA VACCINES AS AN IMPORTANT STEP TOWARD INCREASING LOCAL AND REGIONAL VACCINE SUPPLIES TO RESPOND TO OUTBREAKS. WE ALSO IMPLEMENTED AN INNOVATIVE MOBILE HEALTH APPLICATION TO INCREASE TB TREATMENT ADHERENCE. THE SOFTWARE LINKS TO THE NATIONAL TB TREATMENT MANAGEMENT DATABASE AND SENDS SMS TEXTS TO PATIENTS, REMINDING THEM TO TAKE THEIR MEDICINE AND ATTEND HEALTH CHECKUPS. THE APPLICATION INCREASED TB TREATMENT ADHERENCE FROM 91 TO 98 PERCENT.IN INDIA, PATH IS SUPPORTING IMMUNIZATION CAMPAIGNS AND OTHER MEASURES TO CONTROL JAPANESE ENCEPHALITIS AND ACUTE ENCEPHALITIS SYNDROME. IN THE STATE OF BIHAR, 13.3 MILLION CHILDREN WERE IMMUNIZED AGAINST JAPANESE ENCEPHALITIS. THE STATE OF UTTAR PRADESH ESTABLISHED 100 ENCEPHALITIS TREATMENT CENTERS FOR CLINICAL MANAGEMENT OF THE TWO DISEASES TO PREVENT CHILDREN FROM DYING. FINALLY, AS PART OF PATH'S COMPREHENSIVE STRATEGY TO ELIMINATE MALARIA IN AFRICA, WE WORK WITH NATIONAL MALARIA PROGRAMS IN A NUMBER OF COUNTRIES TO EXPAND COMPREHENSIVE TESTING AND TREATMENT, IMPROVE DATA COLLECTION, AND INCREASE SURVEILLANCE. FOR EXAMPLE, IN SENEGAL, PATH TEAMED UP WITH EMPLOYERS, PHARMACIES, GOVERNMENT AGENCIES, AND OTHERS TO CREATE ZERO-MALARIA-TRANSMISSION ZONES BY PILOTING INNOVATIVE USES OF DRUGS AND DIAGNOSTICS AND BY IMPROVING THE TIMELINESS AND QUALITY OF DATA REPORTING. IN 2013, WE EXPANDED THE APPROACH TO THREE NEW DISTRICTS. WORKING WITH A NETWORK OF PARTNERS IN THE COUNTRY, WE HAVE CONTRIBUTED TO A 62 PERCENT DROP IN MALARIA DEATHS SINCE 2006. | Desc |
Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $50,803,374 | ExpenseAmt |
| Grant | $9,947,242 | GrantAmt |
| Revenue | $1,361 | RevenueAmt |
| Desc | PUBLIC HEALTH IMPACT: PATH WORKS WITH COMMUNITIES AROUND THE WORLD TO DEVELOP NEW SYSTEM AND SERVICE INNOVATIONS AND INTRODUCE PROVEN STRATEGIES TO IMPACT HEALTH OUTCOMES. WE WORK WITH GOVERNMENTS, COMMUNITIES, AND CIVIL-SOCIETY GROUPS TO ENSURE SOLUTIONS ARE APPROPRIATE, AVAILABLE, AND AFFORDABLE TO THOSE WHO NEED THEM. PATH'S PUBLIC HEALTH IMPACT PORTFOLIO DEVELOPS, INTRODUCES, AND SUPPORTS INNOVATIONS FOR THREE CRITICAL HEALTH AREAS: HIV/AIDS AND TB, REPRODUCTIVE HEALTH, AND MATERNAL AND CHILD HEALTH AND NUTRITION.TO REDUCE THE BURDEN OF HIV/AIDS AND TB, PATH FOCUSED ON STRENGTHENING DIAGNOSIS, CARE, AND TREATMENT SERVICES; STEPPING UP PREVENTION EFFORTS, INCLUDING PREVENTING MOTHER-TO-CHILD TRANSMISSION OF HIV; AND BUILDING THE FOUNDATIONS THAT LOCAL AND NATIONAL HEALTH SYSTEMS NEED TO COMBAT BOTH DISEASES. THROUGH A RANGE OF PROJECTS, WE REACHED HUNDREDS OF THOUSANDS OF PEOPLE IN 2013. FOR EXAMPLE, IN THE DEMOCRATIC REPUBLIC OF THE CONGO, THE PATH-LED PROVIC PROJECT REACHED MORE THAN 325,000 PEOPLE WITH HIV PREVENTION, CARE, AND TREATMENT SERVICES IN 2013. WITH OUR PARTNERS, WE LAUNCHED A CLOUD-BASED MONITORING AND EVALUATION DATABASE THAT ANALYZES AND SHARES DATA ACROSS HIV "HOTSPOTS." WHEN THE DATA SHOWED THAT MOTHERS IN A PROGRAM TO PREVENT MOTHER-TO-CHILD HIV TRANSMISSION WERE NOT FOLLOWING UP WITH TREATMENT, WE LAUNCHED A MENTORING PROGRAM THAT DOUBLED THE NUMBER OF WOMEN ON TREATMENT. THROUGH A PROGRAM CALLED ARISE-ENHANCING HIV PREVENTION FOR AT-RISK POPULATIONS-PATH COLLABORATED WITH DIVERSE PARTNERS IN INDIA AND FOUR AFRICAN COUNTRIES TO SCALE UP INNOVATIVE HIV PREVENTION STRATEGIES TARGETED AT VULNERABLE COMMUNITIES-INJECTING DRUG USERS, FEMALE SEX WORKERS, SERODISCORDANT COUPLES, MEN WHO HAVE SEX WITH MEN, AND HIV-POSITIVE WOMEN AND BABIES.PATH ALSO WORKED WITH DIVERSE PARTNERS TO INTEGRATE DETECTION AND CARE FOR TB INTO HEALTH SERVICES FOR CHILD HEALTH, DIABETES, HIV, AND OTHER CONDITIONS. FOR EXAMPLE, WE IMPLEMENTED TB-HIV COLLABORATIVE ACTIVITIES IN 1,125 FACILITIES IN TANZANIA. NEARLY 20,000 PEOPLE DIAGNOSED WITH TB WERE REFERRED FOR HIV TESTING; 22 PERCENT WERE FOUND TO BE HIV POSITIVE AND REGISTERED FOR HIV CARE. THE RATES OF HIV-POSITIVE PATIENTS STARTING TREATMENT INCREASED DRAMATICALLY, FROM 34 PERCENT IN 2012 TO MORE THAN 67 PERCENT IN 2013.PATH'S REPRODUCTIVE HEALTH PROGRAM CONTINUED ITS WORK TO STRENGTHEN ACCESS TO FAMILY PLANNING, IMPROVE SCREENING AND TREATMENT FOR CERVICAL AND BREAST CANCERS, PREVENT SEXUALLY TRANSMITTED INFECTIONS, ADVOCATE FOR SERVICES AND SUPPLIES, INTRODUCE CONTRACEPTIVE TECHNOLOGIES, AND ENCOURAGE HEALTHY BEHAVIORS. ONE OF OUR KEY EFFORTS IN 2013 WAS PAVING THE WAY FOR A NEW FORM OF A POPULAR INJECTABLE CONTRACEPTIVE. THE PRODUCT, SAYANA PRESS, WAS ADAPTED FOR DELIVERY IN THE UNIJECT INJECTION SYSTEM, DEVELOPED BY PATH AND TRADEMARKED BY BD. THE MEDICATION IS CONTAINED IN A SMALL PREFILLED SYRINGE THAT IS EASY TO TRANSPORT AND USE, EXPANDING THE CADRE OF HEALTH WORKERS WHO CAN PROVIDE INJECTIONS. PATH COORDINATED PLANNING AMONG GLOBAL AND COUNTRY PARTNERS IN PREPARATION FOR INTRODUCTION OF SAYANA PRESS IN FOUR AFRICAN COUNTRIES IN 2014. PATH ALSO ENHANCED THE SUSTAINABILITY OF FAMILY PLANNING PROGRAMS IN LOW-AND MIDDLE-INCOME COUNTRIES BY WORKING TO LINK PUBLIC- AND PRIVATE-SECTORS IN COMPRHENSIVE, TOTAL MARKET APPROACHES TO MEET CONTRACEPTIVE NEEDS.PATH ALSO SERVED AS THE SECRETARIAT FOR THE REPRODUCTIVE HEALTH SUPPLIES COALITION, A GLOBAL PARTNERSHIP OF 300 PUBLIC, PRIVATE, AND NONGOVERNMENTAL ORGANIZATIONS WORKING TO EXPAND ACCESS TO SUPPLIES, SERVICES, AND OPTIONS FOR PREVENTING UNINTENDED PREGNANCIES AND SEXUALLY TRANSMITTED INFECTIONS.AS PART OF OUR NONCOMMUNICABLE DISEASES PROGRAM, PATH WORKS TO IMPROVE DETECTION AND TREATMENT OF CERVICAL AND BREAST CANCERS. IN 2013, WE REFINED AND EXPANDED A PILOT PROJECT IN PERU THAT IS INCREASING WOMEN'S ACCESS TO EARLY DETECTION AND TREATMENT OF BREAST CANCER, ADDING A PATIENT NAVIGATION PROGRAM AND CURRICULUM FOR A BIOPSY TECHNIQUE CALLED FINE-NEEDLE ASPIRATION. FINALLY, OUR PUBLIC HEALTH IMPACT PORTFOLIO IMPROVED THE HEALTH OF WOMEN AND CHILDREN THROUGH EVIDENCE-BASED APPROACHES THAT TACKLE THE LEADING CAUSES OF MATERNAL AND CHILD DEATH IN LOW-RESOURCE SETTINGS. POSTPARTUM HEMORRHAGE, OR EXCESSIVE BLEEDING AFTER CHILDBIRTH, IS THE LEADING CAUSE OF MATERNAL DEATH WORLDWIDE. A CLINICAL TRIAL COMPLETED BY PATH'S OXYTOCIN INITIATIVE IN 2013 FOUND THAT USE OF OXYTOCIN IN THE UNIJECT INJECTION SYSTEM BY COMMUNITY HEALTH WORKERS IN GHANA REDUCED THE RISK OF POSTPARTUM HEMORRHAGE DURING HOME-BASED BIRTHS. PATH CO-FACILITATED THE DRAFTING OF A NATIONAL STRATEGY TO ADDRESS POSTPARTUM HEMORRHAGE USING RESULTS AND RECOMMENDATIONS FROM THE CLINICAL TRIAL.IN SOUTH AFRICA AND MOZAMBIQUE, WE CONTINUED TO EXPAND OUR TRAINING AND MENTORING OF MATERNAL AND CHILD HEALTH PROVIDERS THROUGH THE WINDOW OF OPPORTUNITY PROJECT, WHICH SERVES A POPULATION OF APPROXIMATELY 4 MILLION.TO REDUCE NEONATAL MORTALITY AND IMPROVE NUTRITION, PATH IS WORKING TO STRENGTHEN HUMAN MILK BANKING TO ENSURE INFANTS HAVE ACCESS TO DONOR BREAST MILK WHEN THEIR MOTHERS' MILK IS UNAVAILABLE. IN 2013, WE LAUNCHED "STRENGTHENING HUMAN MILK BANKING: A GLOBAL IMPLEMENTATION FRAMEWORK" TO PROVIDE GUIDANCE ON ESTABLISHING SAFE SYSTEMS. WE ALSO COLLABORATED ON THE EVALUATION OF A LOW-COST SYSTEM THAT USES MOBILE PHONES TO MANAGE THE PASTEURIZATION OF DONATED BREAST MILK.THROUGH THE MAXIMISING THE QUALITY OF SCALING UP NUTRITION PROJECT, A PATH-LED CONSORTIUM WORKED WITH OVER 20 COUNTRIES TO ADDRESS UNDERNUTRITION BY BUILDING CAPACITY, GENERATING EVIDENCE, FACILITATING HIGH-QUALITY PROGRAM DESIGN, AND TESTING INNOVATIVE NUTRITION SOLUTIONS. WE ALSO HELPED DEVELOP STRATEGIC DISTRIBUTION MODELS TO INCREASE ACCESS TO RICE FORTIFIED WITH VITAMINS AND MINERALS USING THE ULTRA RICE FORTIFICATION TECHNOLOGY, ADVANCED BY PATH AND TRADEMARKED BY BON DENTE INTERNATIONAL, INC. FORTIFIED GRAINS ARE BEING INTEGRATED INTO LARGE-SCALE FOOD ASSISTANCE PROGRAMS IN BURUNDI AND CAMBODIA, RETAIL CHANNELS IN BRAZIL, AND SMALL-SCALE DISTRIBUTION CHANNELS IN MALI. IN INDIA, WE HELPED ESTABLISH PRODUCTION OF FORTIFIED GRAINS FOR A WORLD FOOD PROGRAMME PILOT PROJECT THAT REACHED 100,000 CHILDREN. | Desc |
Prog Srvc Accom Acty Other ProgSrvcAccomActyOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $7,996,340 | ExpenseAmt |
| Grant | $2,466,837 | GrantAmt |
| Revenue | $823 | RevenueAmt |
| Desc | OTHER PROGRAM SERVICES: PATH'S ADVOCACY AND PUBLIC POLICY PROGRAM WORKS IN THE UNITED STATES, THE INTERNATIONAL ARENA, AND COUNTRIES AND COMMUNITIES AROUND THE WORLD TO HELP POLICYMAKERS UNDERSTAND ISSUES AND MOTIVATE THEM TO COMMIT FUNDING, CRAFT POLICIES, AND SPONSOR INITIATIVES TO STRENGTHEN GLOBAL HEALTH EFFORTS. IN 2013, PATH'S ADVOCACY HELPED TO EXPAND THE MANDATE OF ONE OF THE WORLD'S LARGEST PUBLIC-PRIVATE PARTNERSHIPS FOR RESEARCH AND DEVELOPMENT OF NEW HEALTH TECHNOLOGIES TO FIGHT INFECTIOUS DISEASES. AS A RESULT OF OUR WORK, THE SCOPE OF THE EUROPEAN AND DEVELOPING COUNTRIES CLINICAL TRIALS PARTNERSHIP NOW INCLUDES ACCELERATING CLINICAL TESTING OF TOOLS TO CONTROL NEGLECTED DISEASES LINKED TO POVERTY. OUR IN-COUNTRY SUPPORT ALSO HAD SUCCESS IN ADVANCING HEALTH POLICIES WITH THE POTENTIAL TO IMPROVE THE HEALTH OF WOMEN AND CHILDREN. FOR EXAMPLE, IN ZAMBIA, TWO MAJOR POLICIES TO EXPAND AND IMPROVE NEWBORN HEALTH CARE WERE APPROVED BY THE COUNTRY'S MINISTRY OF HEALTH AS A RESULT OF OUR ADVOCACY AND POLICY DEVELOPMENT SUPPORT TO COUNTRY HEALTH ADVISORS. ZAMBIA IS A COUNTRY WITH HIGH INFANT MORTALITY AND PREVIOUSLY HAD FEW POLICIES TO REDUCE THE PREVENTABLE DEATHS OF NEWBORNS.PATH HAS A STRATEGY TO INTEGRATE, COORDINATE, AND STRATEGICALLY LEVERAGE PATH'S PROGRAMS, INTERVENTIONS, AND STAFF EXPERTISE TO MAXIMIZE IMPACT AND VALUE FOR MONEY. A KEY PART OF THIS WORK IS IMPLEMENTING CAREFULLY TARGETED, MULTIYEAR INITIATIVES CALLED IMPACT INITIATIVES. THROUGH THE IMPACT INITIATIVES, CROSS-PROGRAM TEAMS IDENTIFY HIGH-PRIORITY AREAS FOR IMPROVEMENT, SET INSTITUTIONAL GOALS, AND THEN MOBILIZE RESOURCES TO ACHIEVE THEM. THE 2013 IMPACT INITIATIVE INCLUDE MATERNAL AND NEONATAL HEALTH TECHNOLOGIES, DIARRHEAL DISEASE AND PNEUMONIA, MALARIA, AND FAMILY PLANNING. | Desc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Other Prog Srvc Expense | $7,996,340 | TotalOtherProgSrvcExpenseAmt |
| Total Other Prog Srvc Grant | $2,466,837 | TotalOtherProgSrvcGrantAmt |
| Total Other Prog Srvc Revenue | $823 | TotalOtherProgSrvcRevenueAmt |
| Total Program Service Expenses | $238,505,327 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (1) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (1) | ScheduleBRequiredInd |
| Political Campaign Acty | 0 | PoliticalCampaignActyInd |
| Lobbying Activities | Yes (1) | LobbyingActivitiesInd |
| Subject To Proxy Tax | 0 | SubjectToProxyTaxInd |
| Donor Advised Fund | 0 | DonorAdvisedFundInd |
| Conservation Easements | 0 | ConservationEasementsInd |
| Collections Of Art | 0 | CollectionsOfArtInd |
| Credit Counseling | 0 | CreditCounselingInd |
| Temp Or Permanent Endowments | Yes (1) | TempOrPermanentEndowmentsInd |
| Report Land Building Equipment | Yes (1) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | 0 | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | 0 | ReportProgramRelatedInvstInd |
| Report Other Assets | 0 | ReportOtherAssetsInd |
| Report Other Liabilities | 0 | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | 0 | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | 0 | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | Yes (1) | ConsolidatedAuditFinclStmtInd |
| School Operating | 0 | SchoolOperatingInd |
| Foreign Office | Yes (1) | ForeignOfficeInd |
| Foreign Activities | Yes (1) | ForeignActivitiesInd |
| More Than5000 K To Org | Yes (1) | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | 0 | MoreThan5000KToIndividualsInd |
| Professional Fundraising | 0 | ProfessionalFundraisingInd |
| Fundraising Activities | 0 | FundraisingActivitiesInd |
| Gaming Activities | 0 | GamingActivitiesInd |
| Operate Hospital | 0 | OperateHospitalInd |
| Grants To Organizations | Yes (1) | GrantsToOrganizationsInd |
| Grants To Individuals | 0 | GrantsToIndividualsInd |
| Schedule J Required | Yes (1) | ScheduleJRequiredInd |
| Tax Exempt Bonds | 0 | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | 0 | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | 0 | PYExcessBenefitTransInd |
| Loan Outstanding | 0 | LoanOutstandingInd |
| Grant To Related Person | 0 | GrantToRelatedPersonInd |
| Business Rln With Org Mem | 0 | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | 0 | BusinessRlnWithFamMemInd |
| Business Rln With Officer Ent | 0 | BusinessRlnWithOfficerEntInd |
| Deductible Non Cash Contri | Yes (1) | DeductibleNonCashContriInd |
| Deductible Art Contribution | 0 | DeductibleArtContributionInd |
| Terminate Operations | 0 | TerminateOperationsInd |
| Partial Liquidation | 0 | PartialLiquidationInd |
| Disregarded Entity | 0 | DisregardedEntityInd |
| Related Entity | Yes (1) | RelatedEntityInd |
| Related Organization Ctrl Ent | Yes (1) | RelatedOrganizationCtrlEntInd |
| Transaction With Control Ent | Yes (1) | TransactionWithControlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | 0 | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | 0 | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (1) | ScheduleORequiredInd |
| Info In Schedule O Part V | Yes (X) | InfoInScheduleOPartVInd |
| IRP Document | 230 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (1) | BackupWthldComplianceInd |
| Employee | 694 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (1) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | 0 | UnrelatedBusIncmOverLimitInd |
| Foreign Financial Account | Yes (1) | ForeignFinancialAccountInd |
| Foreign Country | BE | ForeignCountryCd |
| Foreign Country | CB | ForeignCountryCd |
| Foreign Country | CH | ForeignCountryCd |
| Foreign Country | CG | ForeignCountryCd |
| Foreign Country | ET | ForeignCountryCd |
| Foreign Country | FR | ForeignCountryCd |
| Foreign Country | GH | ForeignCountryCd |
| Foreign Country | IN | ForeignCountryCd |
| Foreign Country | MZ | ForeignCountryCd |
| Foreign Country | BM | ForeignCountryCd |
| Foreign Country | NU | ForeignCountryCd |
| Foreign Country | PE | ForeignCountryCd |
| Foreign Country | SZ | ForeignCountryCd |
| Foreign Country | TZ | ForeignCountryCd |
| Foreign Country | TH | ForeignCountryCd |
| Foreign Country | UG | ForeignCountryCd |
| Foreign Country | KE | ForeignCountryCd |
| Foreign Country | UP | ForeignCountryCd |
| Foreign Country | VM | ForeignCountryCd |
| Foreign Country | ZA | ForeignCountryCd |
| Foreign Country | SG | ForeignCountryCd |
| Foreign Country | SF | ForeignCountryCd |
| Prohibited Tax Shelter Trans | 0 | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | 0 | TaxablePartyNotificationInd |
| Nondeductible Contributions | 0 | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | 0 | QuidProQuoContributionsInd |
| Form8282 Property Disposed Of | 0 | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | 0 | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | 0 | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | 0 | IndoorTanningServicesInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 12 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 12 | IndependentVotingMemberCnt |
| Family Or Business Rln | 0 | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | 0 | DelegationOfMgmtDutiesInd |
| Change To Org Documents | 0 | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | 0 | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | 0 | MembersOrStockholdersInd |
| Election Of Board Members | 0 | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | 0 | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (1) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (1) | MinutesOfCommitteesInd |
| Officer Mailing Address | 0 | OfficerMailingAddressInd |
| Local Chapters | 0 | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (1) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (1) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (1) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (1) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (1) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (1) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (1) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (1) | CompensationProcessOtherInd |
| Investment In Joint Venture | 0 | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | AZ | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | FL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | IL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MD | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NJ | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OH | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | PA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | TX | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | VA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | VT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WA | StatesWhereCopyOfReturnIsFldCd |
| Own Website | Yes (X) | OwnWebsiteInd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | OLIVIA POLIUS CHIEF FINANCIAL OFFICER | BusinessNameLine1 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Phone | 2062853500 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 2201 WESTLAKE AVE SUITE 200 | AddressLine1 |
| City | SEATTLE | City |
| State | WA | State |
| ZIP Code | 98121 | ZIPCode |
Form990 Part VII Section A Form990PartVIISectionAGrp (41 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | OfficerOfficerInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | Key EmployeeKeyEmployeeInd | Highest Compensated EmployeeHighestCompensatedEmployeeInd |
|---|---|---|---|---|---|---|---|---|---|
| GEORGE GOTSADZE | |||||||||
| BOARD CHAIR | 2.00 | 0.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| DEAN ALLEN | |||||||||
| BOARD VICE CHAIR & TREASURER | 2.00 | 0.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| EIVOR HALKJAER | |||||||||
| BOARD SECRETARY | 2.00 | 0.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| PHYLLIS CAMPBELL | |||||||||
| DIRECTOR | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| DAVID KING | |||||||||
| DIRECTOR | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| JO ADDY | |||||||||
| DIRECTOR | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| ALEX CHIKA EZEH | |||||||||
| DIRECTOR | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| KEVIN REILLY | |||||||||
| DIRECTOR | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| KOFI AMEGASHIE | |||||||||
| DIRECTOR | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| VINCENT MCGEE | |||||||||
| DIRECTOR | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| RAJENDRA VATTIUTI | |||||||||
| DIRECTOR | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| FELIX OLALE | |||||||||
| DIRECTOR | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| STEVEN B DAVIS | |||||||||
| PRESIDENT AND CEO | 38.00 | 2.00 | Yes (X) | $481,239 | $0 | $41,628 | |||
| ERIC G WALKER | |||||||||
| VP, CORPORATE SVC. (UNTIL 10/2/2013) | 38.00 | 2.00 | Yes (X) | $352,054 | $0 | $34,611 | |||
| OLIVIA POLIUS | |||||||||
| CFO (BEGAN 6/10/2013) | 38.00 | 2.00 | Yes (X) | $99,511 | $0 | $6,116 | |||
| MICHAEL B KOLLINS | |||||||||
| COO (BEGAN 5/31/2013) | 40.00 | 0.00 | Yes (X) | $140,267 | $0 | $12,850 | |||
| DAVID C KASLOW | |||||||||
| VP, PRODUCT DEV. (BEGAN 10/1/2013) | 37.00 | 3.00 | $322,463 | $0 | $39,519 | Yes (X) | |||
| AYORINDE ARNOLD AJAYI | |||||||||
| VP, INTERNATIONAL DEVELOPMENT | 40.00 | 0.00 | $256,904 | $0 | $34,738 | Yes (X) | |||
| SARAH C TEMPLE | |||||||||
| VP, EXTERNAL RELATIONS | 40.00 | 0.00 | $226,095 | $0 | $35,911 | Yes (X) | |||
| DAN LASTER | |||||||||
| GENERAL COUNSEL | 38.00 | 2.00 | $225,160 | $0 | $35,498 | Yes (X) | |||
| JACQUELINE D SHERRIS | |||||||||
| VP, PUBLIC HEALTH IMPACT | 37.00 | 3.00 | $208,881 | $0 | $27,440 | Yes (X) | |||
| KATHRYN A O'DRISCOLL | |||||||||
| CHIEF HUMAN RESOURCES OFFICER | 40.00 | 0.00 | $206,793 | $0 | $35,630 | Yes (X) | |||
| AMIE E BATSON | |||||||||
| CHIEF STRATEGY OFF. (BEGAN 4/8/13) | 39.00 | 1.00 | $193,128 | $0 | $10,579 | Yes (X) | |||
| JOHN W BOSLEGO | |||||||||
| DIRECTOR, VACCINE DEV. GLOBAL PROG. | 40.00 | 0.00 | $319,488 | $0 | $39,990 | Yes (X) | |||
| PAWANA WIENRAWEE | |||||||||
| DIRECTOR, THAILAND PROGRAMS | 40.00 | 0.00 | $284,354 | $0 | $24,004 | Yes (X) | |||
| PONNI SUBBIAH | |||||||||
| DIRECTOR, DRUG DEVELOPMENT | 40.00 | 0.00 | $277,216 | $0 | $31,334 | Yes (X) | |||
| RIKKA E TRANGSRUD | |||||||||
| COUNTRY PROGRAM LEADER, KENYA | 40.00 | 0.00 | $275,656 | $0 | $28,983 | Yes (X) | |||
| TRAD M HATTON | |||||||||
| CHIEF OF PARTY, INTEGRATED HIV/AIDS | 40.00 | 0.00 | $265,397 | $0 | $24,096 | Yes (X) | |||
| CARLOS CLINTON CAMPBELL | |||||||||
| DIRECTOR, MALARIA CONTROL PROGRAM | 40.00 | 0.00 | $254,674 | $0 | $27,863 | Yes (X) | |||
| ANURAG PRABHAKAR MAIRAL | |||||||||
| DIRECTOR, TECHNOLOGY SOLUTIONS | 40.00 | 0.00 | $254,450 | $0 | $25,042 | Yes (X) | |||
| ASHLEY BIRKETT | |||||||||
| DIRECTOR, RESEARCH AND DEVELOPMENT | 40.00 | 0.00 | $245,265 | $0 | $37,215 | Yes (X) | |||
| RAMONA ANNE BYRKIT | |||||||||
| COUNTRY PROGRAM LEADER, VIETNAM | 40.00 | 0.00 | $242,849 | $0 | $29,422 | Yes (X) | |||
| KATHLEEN M NEUZIL | |||||||||
| GLOBAL PROGRAM LEADER, VAD | 40.00 | 0.00 | $234,320 | $0 | $34,920 | Yes (X) | |||
| CATHARINE HOWARD TAYLOR | |||||||||
| GLOBAL PROGRAM LEADER, MCHN | 40.00 | 0.00 | $210,119 | $0 | $32,903 | Yes (X) | |||
| JANE E HUTCHINGS | |||||||||
| DIRECTOR, REPRODUCTIVE HEALTH | 40.00 | 0.00 | $198,328 | $0 | $33,996 | Yes (X) | |||
| RACHEL WILSON | |||||||||
| SENIOR DIRECTOR, POLICY & ADVOCACY | 40.00 | 0.00 | $190,242 | $0 | $32,157 | Yes (X) | |||
| JOHN SKIBIAK | |||||||||
| DIRECTOR, RHSC | 40.00 | 0.00 | $267,549 | $0 | $33,103 | Yes (X) | |||
| JEAN A NTUMBA BIDUAYA | |||||||||
| FIN. & ADMIN. SPECIALIST, HIV & TB | 40.00 | 0.00 | $249,682 | $0 | $18,900 | Yes (X) | |||
| DUNCAN OWENS EARLE | |||||||||
| PROG. DIR., MALARIA CONTROL & EVAL. | 40.00 | 0.00 | $243,590 | $0 | $30,851 | Yes (X) | |||
| BONIFACE MUTOMBO WA MUTOMBO | |||||||||
| SENIOR PROGRAM OFFICER | 40.00 | 0.00 | $240,288 | $0 | $24,848 | Yes (X) | |||
| GEORGE A ROBERTSON | |||||||||
| SENIOR TECHNICAL ADVISOR | 40.00 | 0.00 | $228,411 | $0 | $38,353 | Yes (X) | |||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $7,194,373 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $0 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $862,500 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 211 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | 0 | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (1) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | 0 | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (5 entries)
| Address Line1ContractorAddress/USAddress/AddressLine1 | CityContractorAddress/USAddress/City | StateContractorAddress/USAddress/State | ZIP CodeContractorAddress/USAddress/ZIPCode | ServicesServicesDesc | CompensationCompensationAmt |
|---|---|---|---|---|---|
| SLALOM LLC | |||||
| 821 2ND AVE STE 1900 | SEATTLE | WA | 98124 | GENERAL CONTRACTOR | $1,231,957 |
| WIDENET CONSULTING GROUP LLC | |||||
| 11400 SE 6TH ST | BELLEVUE | WA | 98004 | CONSULTING | $965,834 |
| CURTIS CONSULTING GROUP INC | |||||
| 385 FRONT ST N | ISAQUAH | WA | 98027 | GENERAL CONTRACTOR | $751,650 |
| TERRA SERVICES INC | |||||
| PO BOX 202056 | DALLAS | TX | 75320 | GENERAL CONTRACTOR | $438,076 |
| NORTHERN TRUST | |||||
| 50 S LASALLE ST | CHICAGO | IL | 60675 | ASSET MANAGEMENT | $342,663 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 15 | CntrctRcvdGreaterThan100KCnt |
| Related Organizations | $18,468,421 | RelatedOrganizationsAmt |
| Government Grants | $134,832,852 | GovernmentGrantsAmt |
| All Other Contributions | $107,355,659 | AllOtherContributionsAmt |
| Noncash Contributions | $107,486 | NoncashContributionsAmt |
| Total Contributions | $260,656,932 | TotalContributionsAmt |
Program Service Revenue ProgramServiceRevenueGrp (3 entries)
| DescDesc | BusinessBusinessCd | Total Revenue ColumnTotalRevenueColumnAmt | Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt |
|---|---|---|---|
| HONORARIUM | 900099 | $2,848 | $2,848 |
| SALES | 900099 | $961 | $961 |
| CONSULTANCIES | 541900 | $137 | $137 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Revenue | $3,946 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $1,577,422 | TotalRevenueColumnAmt |
| Exclusion | $1,577,422 | ExclusionAmt |
Royalties Revenue RoyaltiesRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $409 | TotalRevenueColumnAmt |
| Exclusion | $409 | ExclusionAmt |
Gross Amount Sales Assets GrossAmountSalesAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $61,680,200 | SecuritiesAmt |
| Other | $250,594 | OtherAmt |
Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $61,201,314 | SecuritiesAmt |
| Other | $256,506 | OtherAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $478,886 | SecuritiesAmt |
| Other | -$5,912 | OtherAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $472,974 | TotalRevenueColumnAmt |
| Exclusion | $472,974 | ExclusionAmt |
Other Revenue Misc OtherRevenueMiscGrp (3 entries)
| DescDesc | BusinessBusinessCd | Total Revenue ColumnTotalRevenueColumnAmt | ExclusionExclusionAmt |
|---|---|---|---|
| GAIN-FOREIGN EXCH. | 900099 | $2,101,509 | $2,101,509 |
| REIMBURSEMENTS | 900099 | $250,095 | $250,095 |
| OTHER | 900099 | $81,287 | $81,287 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Revenue Total | $2,432,891 | OtherRevenueTotalAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $265,144,574 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $3,946 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $4,483,696 | ExclusionAmt |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $33,377,700 | TotalAmt |
| Program Services | $33,377,700 | ProgramServicesAmt |
Foreign Grants ForeignGrantsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $39,326,884 | TotalAmt |
| Program Services | $39,326,884 | ProgramServicesAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $6,698,256 | TotalAmt |
| Program Services | $3,994,374 | ProgramServicesAmt |
| Management And General | $2,650,930 | ManagementAndGeneralAmt |
| Fundraising | $52,952 | FundraisingAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $72,296,991 | TotalAmt |
| Program Services | $43,261,725 | ProgramServicesAmt |
| Management And General | $28,148,617 | ManagementAndGeneralAmt |
| Fundraising | $886,649 | FundraisingAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $7,030,592 | TotalAmt |
| Management And General | $7,030,592 | ManagementAndGeneralAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $9,663,814 | TotalAmt |
| Program Services | $694,132 | ProgramServicesAmt |
| Management And General | $8,969,682 | ManagementAndGeneralAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $5,936,515 | TotalAmt |
| Program Services | $412,245 | ProgramServicesAmt |
| Management And General | $5,524,270 | ManagementAndGeneralAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $516,660 | TotalAmt |
| Program Services | $118,915 | ProgramServicesAmt |
| Management And General | $397,745 | ManagementAndGeneralAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $555,785 | TotalAmt |
| Program Services | $154,116 | ProgramServicesAmt |
| Management And General | $401,669 | ManagementAndGeneralAmt |
Fees For Services Lobbying FeesForServicesLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $27,000 | TotalAmt |
| Program Services | $12,000 | ProgramServicesAmt |
| Management And General | $15,000 | ManagementAndGeneralAmt |
Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $312,703 | TotalAmt |
| Management And General | $312,703 | ManagementAndGeneralAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $12,598,323 | TotalAmt |
| Program Services | $7,100,364 | ProgramServicesAmt |
| Management And General | $5,317,655 | ManagementAndGeneralAmt |
| Fundraising | $180,304 | FundraisingAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $218,752 | TotalAmt |
| Program Services | $123,356 | ProgramServicesAmt |
| Management And General | $87,605 | ManagementAndGeneralAmt |
| Fundraising | $7,791 | FundraisingAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $6,175,984 | TotalAmt |
| Program Services | $4,877,457 | ProgramServicesAmt |
| Management And General | $1,243,109 | ManagementAndGeneralAmt |
| Fundraising | $55,418 | FundraisingAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,043,538 | TotalAmt |
| Program Services | $371,097 | ProgramServicesAmt |
| Management And General | $623,542 | ManagementAndGeneralAmt |
| Fundraising | $48,899 | FundraisingAmt |
Royalties RoyaltiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $147,271 | TotalAmt |
| Program Services | $144,906 | ProgramServicesAmt |
| Management And General | $2,365 | ManagementAndGeneralAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $9,782,260 | TotalAmt |
| Program Services | $987,844 | ProgramServicesAmt |
| Management And General | $8,792,311 | ManagementAndGeneralAmt |
| Fundraising | $2,105 | FundraisingAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $21,685,946 | TotalAmt |
| Program Services | $19,636,132 | ProgramServicesAmt |
| Management And General | $1,994,331 | ManagementAndGeneralAmt |
| Fundraising | $55,483 | FundraisingAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $8,555,307 | TotalAmt |
| Program Services | $7,950,654 | ProgramServicesAmt |
| Management And General | $439,240 | ManagementAndGeneralAmt |
| Fundraising | $165,413 | FundraisingAmt |
Interest InterestGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $93,052 | TotalAmt |
| Management And General | $93,052 | ManagementAndGeneralAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,453,801 | TotalAmt |
| Program Services | $179,178 | ProgramServicesAmt |
| Management And General | $2,274,623 | ManagementAndGeneralAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $438,243 | TotalAmt |
| Program Services | $118,674 | ProgramServicesAmt |
| Management And General | $319,569 | ManagementAndGeneralAmt |
Other Expenses OtherExpensesGrp (4 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt | Management And GeneralManagementAndGeneralAmt | FundraisingFundraisingAmt |
|---|---|---|---|---|
| SUBCONTRACTS | $34,183,269 | $33,094,547 | $783,874 | $304,848 |
| EQUIP RENT & MAINT | $4,851,665 | $3,607,546 | $1,228,445 | $15,674 |
| FACILITIES ALLOC | $0 | $9,454,348 | -$9,751,809 | $297,461 |
| LEAVE & BENS ALLOC | $0 | $22,902,806 | -$23,376,054 | $473,248 |
All Other Expenses AllOtherExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $7,731,632 | TotalAmt |
| Program Services | $6,604,327 | ProgramServicesAmt |
| Management And General | $748,712 | ManagementAndGeneralAmt |
| Fundraising | $378,593 | FundraisingAmt |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $285,701,943 | TotalAmt |
| Program Services | $238,505,327 | ProgramServicesAmt |
| Management And General | $44,271,778 | ManagementAndGeneralAmt |
| Fundraising | $2,924,838 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $5,456,357 | BOYAmt |
| EOY | $13,397,133 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $7,755,742 | BOYAmt |
| EOY | $40,026,863 | EOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $267,202,359 | BOYAmt |
| EOY | $254,302,858 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $7,835,110 | BOYAmt |
| EOY | $7,771,974 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,621,049 | BOYAmt |
| EOY | $2,850,259 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $34,181,385 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $15,603,671 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $20,359,258 | BOYAmt |
| EOY | $18,577,714 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $196,097,539 | BOYAmt |
| EOY | $148,068,288 | EOYAmt |
Intangible Assets IntangibleAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $403,151 | BOYAmt |
| EOY | $223,973 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $603,218 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $507,730,565 | BOYAmt |
| EOY | $485,822,280 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $53,959,115 | BOYAmt |
| EOY | $52,731,771 | EOYAmt |
Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $5,232,299 | BOYAmt |
| EOY | $4,335,893 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $59,191,414 | BOYAmt |
| EOY | $57,067,664 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows SFAS117 | Yes (X) | OrganizationFollowsSFAS117Ind |
Unrestricted Net Assets UnrestrictedNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $20,660,464 | BOYAmt |
| EOY | $21,836,456 | EOYAmt |
Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $424,503,642 | BOYAmt |
| EOY | $403,540,565 | EOYAmt |
Permanently Rstr Net Assets PermanentlyRstrNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $3,375,045 | BOYAmt |
| EOY | $3,377,595 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $448,539,151 | BOYAmt |
| EOY | $428,754,616 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $507,730,565 | BOYAmt |
| EOY | $485,822,280 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Reconcilation Revenue Expnss | -$20,557,369 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | $772,834 | NetUnrlzdGainsLossesInvstAmt |
| Other Changes In Net Assets | $0 | OtherChangesInNetAssetsAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | 0 | AccountantCompileOrReviewInd |
| FS Audited | Yes (1) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Consolidated Basis Fincl Stmt | Yes (X) | ConsolidatedBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (1) | AuditCommitteeInd |
| Federal Grant Audit Required | Yes (1) | FederalGrantAuditRequiredInd |
| Federal Grant Audit Performed | Yes (1) | FederalGrantAuditPerformedInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Organization170 | Yes (X) | PublicOrganization170Ind |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $257,511,086 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $152,434,405 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $240,628,741 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $171,536,869 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $260,656,932 | CurrentTaxYearAmt |
| Total | $1,082,768,033 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $257,511,086 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $152,434,405 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $240,628,741 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $171,536,869 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $260,656,932 | CurrentTaxYearAmt |
| Total | $1,082,768,033 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Substantial Contributors Tot | $300,921,187 | SubstantialContributorsTotAmt |
| Public Support Total170 | $781,846,846 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $5,825,631 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $4,380,066 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $2,797,154 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $2,295,453 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $1,577,831 | CurrentTaxYearAmt |
| Total | $16,876,135 | TotalAmt |
Other Income170 OtherIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $524,296 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $1,557,958 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $502,596 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $730,742 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $2,432,891 | CurrentTaxYearAmt |
| Total | $5,748,483 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $1,105,392,651 | TotalSupportAmt |
| Gross Receipts Rltd Activities | $228,313 | GrossReceiptsRltdActivitiesAmt |
| Public Support CY170 | 0.70730 | PublicSupportCY170Pct |
| Public Support PY170 | 0.61400 | PublicSupportPY170Pct |
| Thirty Thr Pct Suprt Tests CY170 | Yes (X) | ThirtyThrPctSuprtTestsCY170Ind |
Form990 Schedule A Part IV Form990ScheduleAPartIVGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | SCHEDULE A, PART II, SECTION B, LINE 10 - OTHER INCOME: | FormAndLineReferenceDesc |
| Explanation | REIMBURSEMENTS BY THIRD PARTIES OF EXPENSES INCURRED BY PATH AND OTHER MISCELLANEOUS REVENUE: $331,382 AND GAIN ON FOREIGN EXCHANGE OF $2,101,509. | ExplanationTxt |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule C IRS990ScheduleC
Total Grassroots Lobbying TotalGrassrootsLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $3,098 | FilingOrganizationsTotalAmt |
Total Direct Lobbying TotalDirectLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $103,582 | FilingOrganizationsTotalAmt |
Total Lobbying Expend TotalLobbyingExpendGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $106,680 | FilingOrganizationsTotalAmt |
Other Exempt Purpose Expend OtherExemptPurposeExpendGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $285,595,263 | FilingOrganizationsTotalAmt |
Total Exempt Purpose Expend TotalExemptPurposeExpendGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $285,701,943 | FilingOrganizationsTotalAmt |
Lobbying Nontaxable Amount LobbyingNontaxableAmountGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $1,000,000 | FilingOrganizationsTotalAmt |
Grassroots Nontaxable GrassrootsNontaxableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $250,000 | FilingOrganizationsTotalAmt |
Tot Lbbyng Grassroot Mns Non Tx TotLbbyngGrassrootMnsNonTxGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $0 | FilingOrganizationsTotalAmt |
Tot Lbby Expend Mns Lbbyng Non Tx TotLbbyExpendMnsLbbyngNonTxGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $0 | FilingOrganizationsTotalAmt |
Avg Lobbying Nontaxable Amount AvgLobbyingNontaxableAmountGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Year Minus3 | $1,000,000 | CurrentYearMinus3Amt |
| Current Year Minus2 | $1,000,000 | CurrentYearMinus2Amt |
| Current Year Minus1 | $1,000,000 | CurrentYearMinus1Amt |
| Current Year | $1,000,000 | CurrentYearAmt |
| Total | $4,000,000 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Lobbying Ceiling | $6,000,000 | LobbyingCeilingAmt |
Avg Total Lobbying Expend AvgTotalLobbyingExpendGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Year Minus3 | $219,409 | CurrentYearMinus3Amt |
| Current Year Minus2 | $197,270 | CurrentYearMinus2Amt |
| Current Year Minus1 | $193,545 | CurrentYearMinus1Amt |
| Current Year | $106,680 | CurrentYearAmt |
| Total | $716,904 | TotalAmt |
Avg Grassroots Nontaxable AvgGrassrootsNontaxableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Year Minus3 | $250,000 | CurrentYearMinus3Amt |
| Current Year Minus2 | $250,000 | CurrentYearMinus2Amt |
| Current Year Minus1 | $250,000 | CurrentYearMinus1Amt |
| Current Year | $250,000 | CurrentYearAmt |
| Total | $1,000,000 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grassroots Ceiling | $1,500,000 | GrassrootsCeilingAmt |
Avg Grassroots Lobbying Expend AvgGrassrootsLobbyingExpendGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Year Minus3 | $6,398 | CurrentYearMinus3Amt |
| Current Year | $3,098 | CurrentYearAmt |
| Total | $9,496 | TotalAmt |
Schedule D IRS990ScheduleD
CY Endwmt Fund CYEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $7,806,786 | BeginningYearBalanceAmt |
| Contributions | $2,550 | ContributionsAmt |
| Investment Earnings Or Losses | $1,503,301 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $295,643 | OtherExpendituresAmt |
| End Year Balance | $9,016,994 | EndYearBalanceAmt |
CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $6,868,767 | BeginningYearBalanceAmt |
| Contributions | $5,392 | ContributionsAmt |
| Investment Earnings Or Losses | $932,627 | InvestmentEarningsOrLossesAmt |
| End Year Balance | $7,806,786 | EndYearBalanceAmt |
CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $6,671,532 | BeginningYearBalanceAmt |
| Contributions | $2,700 | ContributionsAmt |
| Investment Earnings Or Losses | $194,535 | InvestmentEarningsOrLossesAmt |
| End Year Balance | $6,868,767 | EndYearBalanceAmt |
CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $5,943,911 | BeginningYearBalanceAmt |
| Contributions | $1,790 | ContributionsAmt |
| Investment Earnings Or Losses | $725,831 | InvestmentEarningsOrLossesAmt |
| End Year Balance | $6,671,532 | EndYearBalanceAmt |
CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $4,752,059 | BeginningYearBalanceAmt |
| Contributions | $2,039 | ContributionsAmt |
| Investment Earnings Or Losses | $1,189,813 | InvestmentEarningsOrLossesAmt |
| End Year Balance | $5,943,911 | EndYearBalanceAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Board Designated Balance EOY | 0.36000 | BoardDesignatedBalanceEOYPct |
| Prmnnt Endowment Balance EOY | 0.37000 | PrmnntEndowmentBalanceEOYPct |
| Term Endowment Balance EOY | 0.27000 | TermEndowmentBalanceEOYPct |
| Endowments Held Unrelated Org | 0 | EndowmentsHeldUnrelatedOrgInd |
| Endowments Held Related Org | 0 | EndowmentsHeldRelatedOrgInd |
Leasehold Improvements LeaseholdImprovementsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $20,110,981 | OtherCostOrOtherBasisAmt |
| Depreciation | $6,385,895 | DepreciationAmt |
| Book Value | $13,725,086 | BookValueAmt |
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $10,580,624 | OtherCostOrOtherBasisAmt |
| Depreciation | $7,809,973 | DepreciationAmt |
| Book Value | $2,770,651 | BookValueAmt |
Other Land Buildings OtherLandBuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $3,489,780 | OtherCostOrOtherBasisAmt |
| Depreciation | $1,407,803 | DepreciationAmt |
| Book Value | $2,081,977 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $18,577,714 | TotalBookValueLandBuildingsAmt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART V, LINE 4: | FormAndLineReferenceDesc |
| Explanation | PATH UTILIZES THE INVESTED INTEREST EARNINGS FROM THE ENDOWMENT AS AN IMPORTANT FUNDING SOURCE TO FUND NEW OPPORTUNITIES TO EXPAND ITS REACH AND IMPACT AS AN ORGANIZATION IN THE FIELD OF GLOBAL HEALTH, IN ACCORDANCE WITH PATH'S ENDOWMENT SPENDING POLICY. | ExplanationTxt |
Schedule F IRS990ScheduleF
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (1) | GrantRecordsMaintainedInd |
Account Activities Outside US AccountActivitiesOutsideUSGrp (46 entries)
| RegionRegionTxt | OfficesOfficesCnt | EmployeeEmployeeCnt | Type Of Activities ConductedTypeOfActivitiesConductedTxt | Region Total ExpendituresRegionTotalExpendituresAmt | Specific Services ProvidedSpecificServicesProvidedTxt |
|---|---|---|---|---|---|
| CENTRAL AMERICA AND THE CARIBBEAN | 1 | 1 | MANAGEMENT & GENERAL | $54,724 | |
| CENTRAL AMERICA AND THE CARIBBEAN | 0 | 0 | PROGRAM SERVICES | $38,698 | INTERNATIONAL DEVELOPMENT |
| CENTRAL AMERICA AND THE CARIBBEAN | 0 | 0 | PROGRAM SERVICES | $166,479 | PUBLIC HEALTH IMPACT |
| EAST ASIA AND THE PACIFIC | 5 | 57 | MANAGEMENT & GENERAL | $2,073,133 | |
| EAST ASIA AND THE PACIFIC | 0 | 0 | PROGRAM SERVICES | $1,074,399 | PRODUCT DEVELOPMENT |
| EAST ASIA AND THE PACIFIC | 0 | 0 | PROGRAM SERVICES | $2,838,159 | INTERNATIONAL DEVELOPMENT |
| EAST ASIA AND THE PACIFIC | 0 | 0 | PROGRAM SERVICES | $141,542 | PUBLIC HEALTH IMPACT |
| EAST ASIA AND THE PACIFIC | 0 | 0 | PROGRAM SERVICES | $146,778 | OTHER |
| EAST ASIA AND THE PACIFIC | 0 | 0 | FUNDRAISING | $31,286 | |
| EAST ASIA AND THE PACIFIC | 0 | 0 | GRANTMAKING | $6,084,748 | |
| EUROPE | 2 | 19 | MANAGEMENT & GENERAL | $2,798,482 | |
| EUROPE | 0 | 0 | PROGRAM SERVICES | $6,265,440 | PRODUCT DEVELOPMENT |
| EUROPE | 0 | 0 | PROGRAM SERVICES | $1,072,713 | INTERNATIONAL DEVELOPMENT |
| EUROPE | 0 | 0 | PROGRAM SERVICES | $3,297,906 | PUBLIC HEALTH IMPACT |
| EUROPE | 0 | 0 | PROGRAM SERVICES | $121,589 | OTHER |
| EUROPE | 0 | 0 | GRANTMAKING | $16,672,917 | |
| MIDDLE EAST AND NORTH AFRICA | 0 | 0 | MANAGEMENT & GENERAL | $19,863 | |
| MIDDLE EAST AND NORTH AFRICA | 0 | 0 | PROGRAM SERVICES | $59,619 | PRODUCT DEVELOPMENT |
| MIDDLE EAST AND NORTH AFRICA | 0 | 0 | PROGRAM SERVICES | $75,235 | PUBLIC HEALTH IMPACT |
| MIDDLE EAST AND NORTH AFRICA | 0 | 0 | FUNDRAISING | $9,734 | |
| MIDDLE EAST AND NORTH AFRICA | 0 | 0 | GRANTMAKING | $48,554 | |
| NORTH AMERICA | 0 | 0 | MANAGEMENT & GENERAL | $33,677 | |
| NORTH AMERICA | 0 | 0 | PROGRAM SERVICES | $508,105 | PRODUCT DEVELOPMENT |
| NORTH AMERICA | 0 | 0 | PROGRAM SERVICES | $154,252 | PUBLIC HEALTH IMPACT |
| RUSSIA & THE NEWLY INDEPENDENT STATES | 1 | 11 | MANAGEMENT & GENERAL | $130,796 | |
| RUSSIA & THE NEWLY INDEPENDENT STATES | 0 | 0 | PROGRAM SERVICES | $169,250 | INTERNATIONAL DEVELOPMENT |
| RUSSIA & THE NEWLY INDEPENDENT STATES | 0 | 0 | PROGRAM SERVICES | $5,272 | PUBLIC HEALTH IMPACT |
| RUSSIA & THE NEWLY INDEPENDENT STATES | 0 | 0 | PROGRAM SERVICES | $12,407 | OTHER |
| RUSSIA & THE NEWLY INDEPENDENT STATES | 0 | 0 | GRANTMAKING | $1,074,197 | |
| SOUTH AMERICA | 1 | 2 | MANAGEMENT & GENERAL | $68,187 | |
| SOUTH AMERICA | 0 | 0 | PROGRAM SERVICES | $53,634 | PRODUCT DEVELOPMENT |
| SOUTH AMERICA | 0 | 0 | PROGRAM SERVICES | $332,586 | PUBLIC HEALTH IMPACT |
| SOUTH AMERICA | 0 | 0 | GRANTMAKING | $436,453 | |
| SOUTH ASIA | 5 | 68 | MANAGEMENT & GENERAL | $1,649,128 | |
| SOUTH ASIA | 0 | 0 | PROGRAM SERVICES | $681,210 | PRODUCT DEVELOPMENT |
| SOUTH ASIA | 0 | 0 | PROGRAM SERVICES | $2,191,355 | INTERNATIONAL DEVELOPMENT |
| SOUTH ASIA | 0 | 0 | PROGRAM SERVICES | $583,036 | PUBLIC HEALTH IMPACT |
| SOUTH ASIA | 0 | 0 | PROGRAM SERVICES | $18,082 | OTHER |
| SOUTH ASIA | 0 | 0 | GRANTMAKING | $2,038,854 | |
| SUB-SAHARAN AFRICA | 19 | 479 | MANAGEMENT & GENERAL | $8,762,172 | |
| SUB-SAHARAN AFRICA | 0 | 0 | PROGRAM SERVICES | $3,429,509 | PRODUCT DEVELOPMENT |
| SUB-SAHARAN AFRICA | 0 | 0 | PROGRAM SERVICES | $30,107,684 | INTERNATIONAL DEVELOPMENT |
| SUB-SAHARAN AFRICA | 0 | 0 | PROGRAM SERVICES | $8,937,913 | PUBLIC HEALTH IMPACT |
| SUB-SAHARAN AFRICA | 0 | 0 | PROGRAM SERVICES | $69,811 | OTHER |
| SUB-SAHARAN AFRICA | 0 | 0 | FUNDRAISING | $1,968 | |
| SUB-SAHARAN AFRICA | 0 | 0 | GRANTMAKING | $12,971,101 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Offices | 6 | SubtotalOfficesCnt |
| Subtotal Employees | 58 | SubtotalEmployeesCnt |
| Continutation Total Office | 28 | ContinutationTotalOfficeCnt |
| Continutation Total Employee | 579 | ContinutationTotalEmployeeCnt |
| Total Office | 34 | TotalOfficeCnt |
| Total Employee | 637 | TotalEmployeeCnt |
| Subtotal Spent | $6,533,912 | SubtotalSpentAmt |
| Continuation Spent | $110,978,725 | ContinuationSpentAmt |
| Total Spent | $117,512,637 | TotalSpentAmt |
Grants To Org Outside US GrantsToOrgOutsideUSGrp (352 entries)
| RegionRegionTxt | Purpose Of GrantPurposeOfGrantTxt | Cash GrantCashGrantAmt | Manner Of Cash DisbursementMannerOfCashDisbursementTxt |
|---|---|---|---|
| EAST ASIA AND PACIFIC | INTERNATIONAL DEVELOPMENT | $300,034 | CHECK/WIRE |
| EAST ASIA AND PACIFIC | INTERNATIONAL DEVELOPMENT | $242,857 | CHECK/WIRE |
| EAST ASIA AND PACIFIC | INTERNATIONAL DEVELOPMENT | $159,953 | CHECK/WIRE |
| EAST ASIA AND PACIFIC | INTERNATIONAL DEVELOPMENT | $130,131 | CHECK/WIRE |
| EAST ASIA AND PACIFIC | INTERNATIONAL DEVELOPMENT | $111,295 | CHECK/WIRE |
| EAST ASIA AND PACIFIC | INTERNATIONAL DEVELOPMENT | $110,531 | CHECK/WIRE |
| EAST ASIA AND PACIFIC | INTERNATIONAL DEVELOPMENT | $104,051 | CHECK/WIRE |
| EAST ASIA AND PACIFIC | INTERNATIONAL DEVELOPMENT | $100,208 | CHECK/WIRE |
| EAST ASIA AND PACIFIC | INTERNATIONAL DEVELOPMENT | $84,692 | CHECK/WIRE |
| EAST ASIA AND PACIFIC | INTERNATIONAL DEVELOPMENT | $76,034 | CHECK/WIRE |
| EAST ASIA AND PACIFIC | INTERNATIONAL DEVELOPMENT | $72,134 | CHECK/WIRE |
| EAST ASIA AND PACIFIC | INTERNATIONAL DEVELOPMENT | $49,444 | CHECK/WIRE |
| EAST ASIA AND PACIFIC | INTERNATIONAL DEVELOPMENT | $49,007 | CHECK/WIRE |
| EAST ASIA AND PACIFIC | INTERNATIONAL DEVELOPMENT | $45,084 | CHECK/WIRE |
| EAST ASIA AND PACIFIC | INTERNATIONAL DEVELOPMENT | $21,552 | CHECK/WIRE |
| EAST ASIA AND PACIFIC | INTERNATIONAL DEVELOPMENT | $20,000 | CHECK/WIRE |
| EAST ASIA AND PACIFIC | INTERNATIONAL DEVELOPMENT | $19,818 | CHECK/WIRE |
| EAST ASIA AND PACIFIC | INTERNATIONAL DEVELOPMENT | $18,289 | CHECK/WIRE |
| EAST ASIA AND PACIFIC | INTERNATIONAL DEVELOPMENT | $9,823 | CHECK/WIRE |
| EAST ASIA AND PACIFIC | INTERNATIONAL DEVELOPMENT | $6,357 | CHECK/WIRE |
| EAST ASIA AND PACIFIC | OTHER | $5,000 | CHECK/WIRE |
| EAST ASIA AND PACIFIC | PRODUCT DEVELOPMENT | $1,152,759 | CHECK/WIRE |
| EAST ASIA AND PACIFIC | PRODUCT DEVELOPMENT | $550,000 | CHECK/WIRE |
| EAST ASIA AND PACIFIC | PRODUCT DEVELOPMENT | $233,775 | CHECK/WIRE |
| EAST ASIA AND PACIFIC | PRODUCT DEVELOPMENT | $140,753 | CHECK/WIRE |
| EAST ASIA AND PACIFIC | PRODUCT DEVELOPMENT | $85,558 | CHECK/WIRE |
| EAST ASIA AND PACIFIC | PRODUCT DEVELOPMENT | $75,000 | CHECK/WIRE |
| EAST ASIA AND PACIFIC | PRODUCT DEVELOPMENT | $61,522 | CHECK/WIRE |
| EAST ASIA AND PACIFIC | PRODUCT DEVELOPMENT | $54,695 | CHECK/WIRE |
| EAST ASIA AND PACIFIC | PRODUCT DEVELOPMENT | $50,000 | CHECK/WIRE |
| EAST ASIA AND PACIFIC | PRODUCT DEVELOPMENT | $32,466 | CHECK/WIRE |
| EAST ASIA AND PACIFIC | PRODUCT DEVELOPMENT | $31,659 | CHECK/WIRE |
| EAST ASIA AND PACIFIC | PRODUCT DEVELOPMENT | $20,000 | CHECK/WIRE |
| EAST ASIA AND PACIFIC | PRODUCT DEVELOPMENT | $15,246 | CHECK/WIRE |
| EAST ASIA AND PACIFIC | PRODUCT DEVELOPMENT | $15,000 | CHECK/WIRE |
| EAST ASIA AND PACIFIC | PRODUCT DEVELOPMENT | $11,000 | CHECK/WIRE |
| EAST ASIA AND PACIFIC | PRODUCT DEVELOPMENT | $10,000 | CHECK/WIRE |
| EAST ASIA AND PACIFIC | PRODUCT DEVELOPMENT | $9,000 | CHECK/WIRE |
| EAST ASIA AND PACIFIC | PUBLIC HEALTH IMPACT | $1,823,666 | CHECK/WIRE |
| EAST ASIA AND PACIFIC | PUBLIC HEALTH IMPACT | $30,000 | CHECK/WIRE |
| EUROPE | OTHER | $280,627 | CHECK/WIRE |
| EUROPE | PRODUCT DEVELOPMENT | $4,105,785 | CHECK/WIRE |
| EUROPE | PRODUCT DEVELOPMENT | $1,206,054 | CHECK/WIRE |
| EUROPE | PRODUCT DEVELOPMENT | $1,110,000 | CHECK/WIRE |
| EUROPE | PRODUCT DEVELOPMENT | $960,344 | CHECK/WIRE |
| EUROPE | PRODUCT DEVELOPMENT | $750,000 | CHECK/WIRE |
| EUROPE | PRODUCT DEVELOPMENT | $475,523 | CHECK/WIRE |
| EUROPE | PRODUCT DEVELOPMENT | $568,601 | CHECK/WIRE |
| EUROPE | PRODUCT DEVELOPMENT | $481,649 | CHECK/WIRE |
| EUROPE | PRODUCT DEVELOPMENT | $296,305 | CHECK/WIRE |
| EUROPE | PRODUCT DEVELOPMENT | $252,639 | CHECK/WIRE |
| EUROPE | PRODUCT DEVELOPMENT | $243,354 | CHECK/WIRE |
| EUROPE | PRODUCT DEVELOPMENT | $236,942 | CHECK/WIRE |
| EUROPE | PRODUCT DEVELOPMENT | $204,101 | CHECK/WIRE |
| EUROPE | PRODUCT DEVELOPMENT | $203,549 | CHECK/WIRE |
| EUROPE | PRODUCT DEVELOPMENT | $200,000 | CHECK/WIRE |
| EUROPE | PRODUCT DEVELOPMENT | $183,600 | CHECK/WIRE |
| EUROPE | PRODUCT DEVELOPMENT | $173,893 | CHECK/WIRE |
| EUROPE | PRODUCT DEVELOPMENT | $151,512 | CHECK/WIRE |
| EUROPE | PRODUCT DEVELOPMENT | $129,000 | CHECK/WIRE |
| EUROPE | PRODUCT DEVELOPMENT | $99,292 | CHECK/WIRE |
| EUROPE | PRODUCT DEVELOPMENT | $88,590 | CHECK/WIRE |
| EUROPE | PRODUCT DEVELOPMENT | $70,000 | CHECK/WIRE |
| EUROPE | PRODUCT DEVELOPMENT | $64,131 | CHECK/WIRE |
| EUROPE | PRODUCT DEVELOPMENT | $43,000 | CHECK/WIRE |
| EUROPE | PRODUCT DEVELOPMENT | $38,753 | CHECK/WIRE |
| EUROPE | PRODUCT DEVELOPMENT | $34,488 | CHECK/WIRE |
| EUROPE | PRODUCT DEVELOPMENT | $33,280 | CHECK/WIRE |
| EUROPE | PRODUCT DEVELOPMENT | $25,358 | CHECK/WIRE |
| EUROPE | PRODUCT DEVELOPMENT | $19,924 | CHECK/WIRE |
| EUROPE | PRODUCT DEVELOPMENT | $12,802 | CHECK/WIRE |
| EUROPE | PRODUCT DEVELOPMENT | $12,539 | CHECK/WIRE |
| EUROPE | PUBLIC HEALTH IMPACT | $300,354 | CHECK/WIRE |
| EUROPE | PUBLIC HEALTH IMPACT | $114,412 | CHECK/WIRE |
| EUROPE | PUBLIC HEALTH IMPACT | $59,684 | CHECK/WIRE |
| EUROPE | PUBLIC HEALTH IMPACT | $53,370 | CHECK/WIRE |
| EUROPE | PUBLIC HEALTH IMPACT | $50,000 | CHECK/WIRE |
| EUROPE | PUBLIC HEALTH IMPACT | $33,253 | CHECK/WIRE |
| EUROPE | PUBLIC HEALTH IMPACT | $18,212 | CHECK/WIRE |
| EUROPE | INTERNATIONAL DEVELOPMENT | $3,352,920 | CHECK/WIRE |
| MIDDLE EAST AND NORTH AFRICA | PUBLIC HEALTH IMPACT | $39,999 | CHECK/WIRE |
| MIDDLE EAST AND NORTH AFRICA | PUBLIC HEALTH IMPACT | $8,555 | CHECK/WIRE |
| RUSSIA & THE NEWLY INDEPENDENT STATES | INTERNATIONAL DEVELOPMENT | $126,105 | CHECK/WIRE |
| RUSSIA & THE NEWLY INDEPENDENT STATES | INTERNATIONAL DEVELOPMENT | $28,505 | CHECK/WIRE |
| RUSSIA & THE NEWLY INDEPENDENT STATES | PRODUCT DEVELOPMENT | $919,588 | CHECK/WIRE |
| SOUTH AMERICA | PRODUCT DEVELOPMENT | $136,834 | CHECK/WIRE |
| SOUTH AMERICA | PRODUCT DEVELOPMENT | $39,177 | CHECK/WIRE |
| SOUTH AMERICA | PRODUCT DEVELOPMENT | $31,046 | CHECK/WIRE |
| SOUTH AMERICA | PRODUCT DEVELOPMENT | $22,370 | CHECK/WIRE |
| SOUTH AMERICA | PRODUCT DEVELOPMENT | $10,000 | CHECK/WIRE |
| SOUTH AMERICA | PUBLIC HEALTH IMPACT | $159,298 | CHECK/WIRE |
| SOUTH AMERICA | PUBLIC HEALTH IMPACT | $15,126 | CHECK/WIRE |
| SOUTH AMERICA | PUBLIC HEALTH IMPACT | $7,298 | CHECK/WIRE |
| SOUTH AMERICA | PUBLIC HEALTH IMPACT | $6,304 | CHECK/WIRE |
| SOUTH AMERICA | PUBLIC HEALTH IMPACT | $6,000 | CHECK/WIRE |
| SOUTH ASIA | INTERNATIONAL DEVELOPMENT | $604,430 | CHECK/WIRE |
| SOUTH ASIA | PRODUCT DEVELOPMENT | $259,447 | CHECK/WIRE |
| SOUTH ASIA | PRODUCT DEVELOPMENT | $222,095 | CHECK/WIRE |
| SOUTH ASIA | PRODUCT DEVELOPMENT | $211,547 | CHECK/WIRE |
| SOUTH ASIA | PRODUCT DEVELOPMENT | $150,000 | CHECK/WIRE |
| SOUTH ASIA | PRODUCT DEVELOPMENT | $143,851 | CHECK/WIRE |
| SOUTH ASIA | PRODUCT DEVELOPMENT | $130,311 | CHECK/WIRE |
| SOUTH ASIA | PRODUCT DEVELOPMENT | $100,000 | CHECK/WIRE |
| SOUTH ASIA | PRODUCT DEVELOPMENT | $75,000 | CHECK/WIRE |
| SOUTH ASIA | PRODUCT DEVELOPMENT | $20,000 | CHECK/WIRE |
| SOUTH ASIA | PRODUCT DEVELOPMENT | $18,019 | CHECK/WIRE |
| SOUTH ASIA | PRODUCT DEVELOPMENT | $17,441 | CHECK/WIRE |
| SOUTH ASIA | PRODUCT DEVELOPMENT | $13,521 | CHECK/WIRE |
| SOUTH ASIA | PRODUCT DEVELOPMENT | $10,000 | CHECK/WIRE |
| SOUTH ASIA | PRODUCT DEVELOPMENT | $10,000 | CHECK/WIRE |
| SOUTH ASIA | PUBLIC HEALTH IMPACT | $14,710 | CHECK/WIRE |
| SOUTH ASIA | PUBLIC HEALTH IMPACT | $12,835 | CHECK/WIRE |
| SOUTH ASIA | PUBLIC HEALTH IMPACT | $9,609 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $974,571 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $632,960 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $205,314 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $108,717 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $92,988 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $82,187 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $81,887 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $58,968 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $58,033 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $55,084 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $53,761 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $52,401 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $52,047 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $50,802 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $50,510 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $50,375 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $49,354 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $47,014 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $46,182 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $45,899 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $45,729 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $45,420 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $45,277 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $45,268 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $44,662 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $43,085 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $43,063 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $42,936 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $42,726 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $42,670 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $42,661 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $42,118 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $42,096 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $41,602 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $41,287 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $41,127 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $41,030 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $40,504 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $39,451 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $39,375 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $38,536 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $37,658 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $37,492 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $37,492 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $37,425 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $36,825 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $35,683 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $35,650 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $35,627 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $35,562 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $34,852 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $34,263 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $34,142 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $33,789 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $33,195 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $33,044 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $32,758 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $32,332 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $32,021 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $32,001 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $31,381 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $30,719 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $30,702 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $30,600 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $28,556 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $28,512 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $28,396 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $28,021 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $27,429 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $26,497 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $25,855 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $25,151 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $24,299 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $23,633 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $23,616 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $23,030 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $22,795 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $22,743 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $22,631 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $22,229 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $21,377 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $21,040 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $20,092 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $19,412 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $18,269 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $17,034 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $15,704 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $11,282 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $10,472 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $5,557 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | INTERNATIONAL DEVELOPMENT | $5,170 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $19,978 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $18,934 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $17,755 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $15,885 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $15,872 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $15,641 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $15,632 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $15,048 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $14,580 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $14,317 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $14,104 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $14,054 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $13,995 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $13,737 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $13,672 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $12,940 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $12,885 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $12,810 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $12,655 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $12,525 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $12,441 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $12,339 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $12,042 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $11,958 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $11,857 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $11,786 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $11,770 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $11,623 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $11,591 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $11,306 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $10,897 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $10,612 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $10,467 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $10,391 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $9,877 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $9,708 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $9,570 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $9,276 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $9,101 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $9,037 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $9,015 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $9,011 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $8,630 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $8,602 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $8,456 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $8,430 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $8,212 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $7,984 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $7,900 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $7,819 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $7,795 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $7,720 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $7,690 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $7,569 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $7,368 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $6,400 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $6,273 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $6,166 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $6,126 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $5,743 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $5,732 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $5,730 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $5,689 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $5,460 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $5,388 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $229,993 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $207,445 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $197,642 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $194,604 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $168,621 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $137,526 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $136,999 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $114,244 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $113,937 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $94,380 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $91,774 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $86,770 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $85,315 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $78,785 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $64,370 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $55,712 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $53,547 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $50,000 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $41,909 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $41,254 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $41,068 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $40,558 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $34,798 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $33,041 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $29,621 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $26,300 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $25,000 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PUBLIC HEALTH IMPACT | $22,099 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | OTHER | $10,000 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | OTHER | $10,000 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | OTHER | $10,000 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | OTHER | $10,000 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | OTHER | $9,925 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | OTHER | $9,920 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | OTHER | $9,000 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | OTHER | $9,000 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | OTHER | $9,000 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | OTHER | $8,000 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | OTHER | $6,039 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | OTHER | $5,500 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | OTHER | $5,000 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | OTHER | $5,000 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | OTHER | $5,000 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | OTHER | $5,000 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | OTHER | $5,000 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | OTHER | $5,000 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PRODUCT DEVELOPMENT | $667,324 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PRODUCT DEVELOPMENT | $641,489 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PRODUCT DEVELOPMENT | $540,675 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PRODUCT DEVELOPMENT | $405,645 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PRODUCT DEVELOPMENT | $341,897 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PRODUCT DEVELOPMENT | $175,000 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PRODUCT DEVELOPMENT | $169,804 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PRODUCT DEVELOPMENT | $165,650 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PRODUCT DEVELOPMENT | $113,570 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PRODUCT DEVELOPMENT | $83,267 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PRODUCT DEVELOPMENT | $81,287 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PRODUCT DEVELOPMENT | $79,989 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PRODUCT DEVELOPMENT | $78,627 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PRODUCT DEVELOPMENT | $72,429 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PRODUCT DEVELOPMENT | $71,668 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PRODUCT DEVELOPMENT | $66,460 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PRODUCT DEVELOPMENT | $64,561 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PRODUCT DEVELOPMENT | $62,162 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PRODUCT DEVELOPMENT | $56,462 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PRODUCT DEVELOPMENT | $49,988 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PRODUCT DEVELOPMENT | $47,664 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PRODUCT DEVELOPMENT | $45,200 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PRODUCT DEVELOPMENT | $44,502 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PRODUCT DEVELOPMENT | $44,179 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PRODUCT DEVELOPMENT | $42,661 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PRODUCT DEVELOPMENT | $31,603 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PRODUCT DEVELOPMENT | $30,000 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PRODUCT DEVELOPMENT | $27,976 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PRODUCT DEVELOPMENT | $27,018 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PRODUCT DEVELOPMENT | $23,747 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PRODUCT DEVELOPMENT | $23,027 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PRODUCT DEVELOPMENT | $20,136 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PRODUCT DEVELOPMENT | $15,562 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PRODUCT DEVELOPMENT | $15,257 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PRODUCT DEVELOPMENT | $12,356 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PRODUCT DEVELOPMENT | $8,000 | CHECK/WIRE |
| SUB-SAHARAN AFRICA | PRODUCT DEVELOPMENT | $7,924 | CHECK/WIRE |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 255 | Total501c3OrgCnt |
| Total Other Org | 45 | TotalOtherOrgCnt |
| Transfer To Foreign Corp | Yes (1) | TransferToForeignCorpInd |
| Interest In Foreign Trust | 0 | InterestInForeignTrustInd |
| Foreign Corp Ownership | 0 | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | 0 | PassiveForeignInvestmestCoInd |
| Foreign Partnership | 0 | ForeignPartnershipInd |
| Boycott Countries | 0 | BoycottCountriesInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 2: | FormAndLineReferenceDesc |
| Explanation | SUBRECIPIENTS MUST SUBMIT PROGRESS REPORTS THAT ARE REVIEWED BY RESPONSIBLE PATH PROGRAM MANAGERS AND PROGRAM ADMINISTRATORS TO ENSURE THAT PROGRAM GOALS ARE ATTAINED IN ACCORDANCE WITH AGREEMENT REQUIREMENTS. THE RESPONSIBLE PROGRAM MANAGERS AND PROGRAM ADMINISTRATORS CONTACT SUBRECIPIENTS WITH QUESTIONS OR FOLLOW UP ON ANY AREA OF CONCERN. IN SOME CASES, SUBAWARD TERMS MAY REQUIRE SPECIFIED DELIVERABLES IN ADDITION TO, OR IN LIEU OF, TECHNICAL REPORTS. IN ADDITION, DISCRETIONARY ON-SITE VISITS ARE CONDUCTED TO EVALUATE BOTH COMPLIANCE WITH THE SCIENTIFIC OBJECTIVES OF THE PROJECT AND THE APPROPRIATENESS OF THE SUBRECIPIENT'S ADMINISTRATIVE SYSTEMS AND PROCESSES. PATH ALSO USES CROSS-PROGRAM INDICATORS TO TRACK OVERALL ORGANIZATIONAL PERFORMANCE AND LINK OUR WORK AND THE WORK OF SUBRECIPIENTS TO SPECIFIC IMPROVEMENTS IN HEALTH-RELATED OUTCOMES. MONITORING THIS SET OF INDICATORS HELPS PATH SET FUTURE BENCHMARKS AND ADOPT BEST PRACTICES THAT IMPROVE PROGRAMMATIC EFFECTIVENESS OVER TIME. | ExplanationTxt |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (1) | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (116 entries)
| Address Line1USAddress/AddressLine1 | CityUSAddress/City | StateUSAddress/State | ZIP CodeUSAddress/ZIPCode | Recipient EINRecipientEIN | IRC SectionIRCSectionDesc | Cash GrantCashGrantAmt | Purpose Of GrantPurposeOfGrantTxt | Address Line2USAddress/AddressLine2 |
|---|---|---|---|---|---|---|---|---|
| AKROS INC - RESEARCH ANALYTICS | ||||||||
| 3350 LAZERA RANCH ROAD | CHEYENNE | WY | 82007 | 263668995 | N/A | $970,561 | INTERNATIONAL DEVELOPMENT | |
| AKROS INC - RESEARCH ANALYTICS | ||||||||
| 3350 LAZERA RANCH ROAD | CHEYENNE | WY | 82007 | 263668995 | N/A | $182,472 | INTERNATIONAL DEVELOPMENT | |
| AKROS INC - RESEARCH ANALYTICS | ||||||||
| 3350 LAZERA RANCH ROAD | CHEYENNE | WY | 82007 | 263668995 | N/A | $11,884 | INTERNATIONAL DEVELOPMENT | |
| BOSTON UNIVERSITY | ||||||||
| ONE SILBER WAY | BOSTON | MA | 02215 | 042103547 | 501(C)(3) | $80,220 | INTERNATIONAL DEVELOPMENT | |
| ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION (EGPAF) | ||||||||
| 1140 CONNECTICUT AVENUE NW | WASHINGTON | DC | 20036 | 954191698 | 501(C)(3) | $3,512,395 | INTERNATIONAL DEVELOPMENT | |
| ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION (EGPAF) | ||||||||
| 1140 CONNECTICUT AVENUE NW | WASHINGTON | DC | 20036 | 954191698 | 501(C)(3) | $203,604 | INTERNATIONAL DEVELOPMENT | |
| FAMILY HEALTH INTERNATIONAL (FHI) 360 | ||||||||
| PO BOX 13950 2224 E NC HWY 54 | DURHAM | NC | 27713 | 237413005 | 501(C)(3) | $225,780 | INTERNATIONAL DEVELOPMENT | |
| HARVARD SCHOOL OF PUBLIC HEALTH | ||||||||
| INTERNATIONAL HEALTH 665 HUNTINGTON | BOSTON | MA | 02215 | 042103580 | 501(C)(3) | $120,748 | INTERNATIONAL DEVELOPMENT | AVENUE |
| HEALTH ALLIANCE INTERNATIONAL | ||||||||
| 4534 11TH AVE NE | SEATTLE | WA | 98105 | 951831116 | 501(C)(3) | $55,783 | INTERNATIONAL DEVELOPMENT | |
| JHPIEGO CORPORATION | ||||||||
| 1615 THAMES STREET | BALTIMORE | MD | 21231 | 237424444 | 501(C)(3) | $3,538,689 | INTERNATIONAL DEVELOPMENT | |
| MEDICAL CARE DEVELOPMENT INC (MCD) | ||||||||
| 8401 COLESVILLE ROAD 425 | SILVER SPRING | MD | 20910 | 016022787 | 501(C)(3) | $1,627,303 | INTERNATIONAL DEVELOPMENT | |
| POPULATION SERVICES INTERNATIONAL (PSI) | ||||||||
| 1120 19TH STREET NW SUITE 600 | WASHINGTON | DC | 20036 | 560942853 | 501(C)(3) | $213,296 | INTERNATIONAL DEVELOPMENT | |
| SAVE THE CHILDREN | ||||||||
| 501 KINGS HWY E | FAIRFIELD | CT | 068254861 | 060726487 | 501(C)(3) | $145,728 | INTERNATIONAL DEVELOPMENT | |
| TULANE UNIVERSITY | ||||||||
| TULANE SCHOOL OF PUBLIC HEALTH 1440 | NEW ORLEANS | LA | 70112 | 720423889 | 501(C)(3) | $178,440 | INTERNATIONAL DEVELOPMENT | CANAL ST SUITE 2200 |
| WORLD VISION | ||||||||
| P O BOX 9716 DEPT W | FEDERAL WAY | WA | 980639716 | 951922279 | 501(C)(3) | $3,440,000 | INTERNATIONAL DEVELOPMENT | |
| AIDS VACCINE ADVOCACY COALITION | ||||||||
| 423 W 127TH ST FL 4 | NEW YORK | NY | 10027 | 943240841 | 501(C)(3) | $5,000 | OTHER | |
| POPULATION ACTION INTERNATIONAL | ||||||||
| 1300 19TH STREET NW | WASHINGTON | DC | 20036 | 520812075 | 501(C)(3) | $111,686 | OTHER | |
| WOMEN DELIVER | ||||||||
| 588 BROADWAY SUITE 5033 | NEW YORK | NY | 10012 | 264462256 | 501(C)(3) | $60,000 | OTHER | |
| ACCELOVANCE INC | ||||||||
| 2275 RESEARCH BOULEVARD | ROCKVILLE | MD | 20850 | 200956757 | N/A | $140,614 | PRODUCT DEVELOPMENT | |
| ADVANCED BIOSCIENCE LABORATORIES INC | ||||||||
| 9800 MEDICAL CENTER DRIVE BUILDING | ROCKVILLE | MD | 20850 | 621242262 | N/A | $173,200 | PRODUCT DEVELOPMENT | D |
| BERKELEY AIR MONITORING GROUP | ||||||||
| 2124 KITTREDGE STREET 57 | BERKELEY | CA | 94704 | 263881064 | N/A | $86,580 | PRODUCT DEVELOPMENT | |
| CASCADE DESIGNS INC | ||||||||
| 4000 FIRST AVENUE SOUTH | SEATTLE | WA | 98134 | 910969695 | N/A | $13,437 | PRODUCT DEVELOPMENT | |
| CASCADE DESIGNS INC | ||||||||
| 4000 FIRST AVENUE SOUTH | SEATTLE | WA | 98134 | 910969695 | N/A | $12,331 | PRODUCT DEVELOPMENT | |
| CDC FOUNDATION | ||||||||
| 55 PARK PLACE NE SUITE 400 | ATLANTA | GA | 30303 | 582106707 | 501(C)(3) | $392,954 | PRODUCT DEVELOPMENT | |
| CDC FOUNDATION | ||||||||
| 55 PARK PLACE NE SUITE 400 | ATLANTA | GA | 30303 | 582106707 | 501(C)(3) | $30,920 | PRODUCT DEVELOPMENT | |
| CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER) | ||||||||
| US FOOD DRUG ADMINISTRATION 8800 | BETHESDA | MD | 20892 | 530196965 | GOVERNMENT | $75,000 | PRODUCT DEVELOPMENT | ROCKVILLE PIKE |
| CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) | ||||||||
| 1600 CLIFTON ROAD | ATLANTA | GA | 30333 | 586051157 | GOVERNMENT | $155,102 | PRODUCT DEVELOPMENT | |
| CONRAD | ||||||||
| EASTERN VIRGINIA MEDICAL SCHOOL | ARLINGTON | VA | 22209 | 237053028 | 501(C)(3) | $59,064 | PRODUCT DEVELOPMENT | 1911 NORTH FORT MYER DRIVE SUITE 90 |
| DIGITAL GREEN FOUNDATION | ||||||||
| 2342 SHATTUCK AVENUE 151 | BERKELEY | CA | 94704 | 262418959 | 501(C)(3) | $7,101 | PRODUCT DEVELOPMENT | |
| EXPRESSION ANALYSIS INC | ||||||||
| 4324 S ALSTON AVE 101 | DURHAM | NC | 27713 | 522340631 | N/A | $544,850 | PRODUCT DEVELOPMENT | |
| FOOD & DRUG ADMINISTRATION (FDA) | ||||||||
| 10903 NEW HAMPSHIRE AVENUE | SILVER SPRING | MD | 20993 | 530196965 | GOVERNMENT | $629,872 | PRODUCT DEVELOPMENT | |
| FOOD & DRUG ADMINISTRATION (FDA) | ||||||||
| 10903 NEW HAMPSHIRE AVENUE | SILVER SPRING | MD | 20993 | 530196965 | GOVERNMENT | $55,000 | PRODUCT DEVELOPMENT | |
| FRED HUTCHINSON CANCER RESEARCH CENTER | ||||||||
| PO BOX 19024 | SEATTLE | WA | 98109 | 237156071 | 501(C)(3) | $130,545 | PRODUCT DEVELOPMENT | |
| FRED HUTCHINSON CANCER RESEARCH CENTER | ||||||||
| PO BOX 19024 | SEATTLE | WA | 98109 | 237156071 | 501(C)(3) | $8,016 | PRODUCT DEVELOPMENT | |
| GEORGE WASHINGTON UNIVERSITY | ||||||||
| 2175 K STREET NW SUITE 700 | WASHINGTON | DC | 20037 | 530196584 | 501(C)(3) | $17,335 | PRODUCT DEVELOPMENT | |
| GORDON RESEARCH CONFERENCES | ||||||||
| 512 LIBERTY LANE WEST | KINGSTON | RI | 02892 | 260150662 | 501(C)(3) | $20,000 | PRODUCT DEVELOPMENT | |
| INOVIO BIOMEDICAL CORPORATION | ||||||||
| 450 SENTRY PARKWAY | BLUE BELL | PA | 19422 | 330969592 | N/A | $460,592 | PRODUCT DEVELOPMENT | |
| INTERNATIONAL AIDS VACCINE INITIATIVE (IAVI) | ||||||||
| 125 BROAD STREET 9TH FLOOR | NEW YORK | NY | 10004 | 133870223 | 501(C)(3) | $63,920 | PRODUCT DEVELOPMENT | |
| JOHN SNOW INC (JSI) | ||||||||
| 44 FARNSWORTH STREET | BOSTON | MA | 02210 | 042578580 | N/A | $335,548 | PRODUCT DEVELOPMENT | |
| JOHN SNOW INC (JSI) | ||||||||
| 44 FARNSWORTH STREET | BOSTON | MA | 02210 | 042578580 | N/A | $59,424 | PRODUCT DEVELOPMENT | |
| JOHNS HOPKINS UNIVERSITY (JHU) | ||||||||
| 3400 N CHARLES ST | BALTIMORE | MD | 21218 | 131687001 | 501(C)(3) | $112,491 | PRODUCT DEVELOPMENT | |
| JOHNS HOPKINS UNIVERSITY (JHU) | ||||||||
| 3400 N CHARLES ST | BALTIMORE | MD | 21218 | 131687001 | 501(C)(3) | $69,970 | PRODUCT DEVELOPMENT | |
| JOHNS HOPKINS UNIVERSITY (JHU) | ||||||||
| 3400 N CHARLES ST | BALTIMORE | MD | 21218 | 131687001 | 501(C)(3) | $59,557 | PRODUCT DEVELOPMENT | |
| JOHNS HOPKINS UNIVERSITY (JHU) | ||||||||
| 3400 N CHARLES ST | BALTIMORE | MD | 21218 | 131687001 | 501(C)(3) | $23,252 | PRODUCT DEVELOPMENT | |
| JOHNS HOPKINS UNIVERSITY (JHU) | ||||||||
| 3400 N CHARLES ST | BALTIMORE | MD | 21218 | 131687001 | 501(C)(3) | $17,325 | PRODUCT DEVELOPMENT | |
| JOHNS HOPKINS UNIVERSITY (JHU) | ||||||||
| 3400 N CHARLES ST | BALTIMORE | MD | 21218 | 131687001 | 501(C)(3) | $10,536 | PRODUCT DEVELOPMENT | |
| JOHNS HOPKINS UNIVERSITY (JHU) | ||||||||
| 3400 N CHARLES ST | BALTIMORE | MD | 21218 | 131687001 | 501(C)(3) | $9,569 | PRODUCT DEVELOPMENT | |
| LOYOLA UNIVERSITY CHICAGO | ||||||||
| 6339 N SHERIDAN ROAD | CHICAGO | IL | 60660 | 361408475 | 501(C)(3) | $171,035 | PRODUCT DEVELOPMENT | |
| NAT INS OF ALLERGY & INFECTIOUS DISEASES (NIAID) | ||||||||
| 6610 ROCKLEDGE DRIVE SUITE 2800 MSC | BETHESDA | MD | 208926606 | 520858115 | GOVERNMENT | $955,525 | PRODUCT DEVELOPMENT | 6606 |
| NAT INS OF ALLERGY & INFECTIOUS DISEASES (NIAID) | ||||||||
| 6610 ROCKLEDGE DRIVE SUITE 2800 MSC | BETHESDA | MD | 208926606 | 520858115 | GOVERNMENT | $630,611 | PRODUCT DEVELOPMENT | 6606 |
| NAT INS OF ALLERGY & INFECTIOUS DISEASES (NIAID) | ||||||||
| 6610 ROCKLEDGE DRIVE SUITE 2800 MSC | BETHESDA | MD | 208926606 | 520858115 | GOVERNMENT | $192,414 | PRODUCT DEVELOPMENT | 6606 |
| NEW YORK UNIVERSITY | ||||||||
| 105 E 17TH ST 4TH FLOOR | NEW YORK | NY | 100039530 | 135562308 | 501(C)(3) | $138,302 | PRODUCT DEVELOPMENT | |
| NORTIS INC | ||||||||
| C4C NEW VENTURE FACILITY 4000 MASON | SEATTLE | WA | 98195 | 680649212 | N/A | $418,004 | PRODUCT DEVELOPMENT | RD ROOM 304 FLUKE HALL PO BOX 35214 |
| NORTIS INC | ||||||||
| C4C NEW VENTURE FACILITY 4000 MASON | SEATTLE | WA | 98195 | 680649212 | N/A | $15,003 | PRODUCT DEVELOPMENT | RD ROOM 304 FLUKE HALL PO BOX 35214 |
| PATH DRUG SOLUTIONS | ||||||||
| 2201 WESTLAKE AVE SUITE 200 | SEATTLE | WA | 98121 | 943384500 | 501(C)(3) | $535,489 | GENERAL SUPPORT | |
| PATH VACINNE SOLUTIONS | ||||||||
| 2201 WESTLAKE AVE SUITE 200 | SEATTLE | WA | 98121 | 830431851 | 501(C)(3) | $424,773 | GENERAL SUPPORT | |
| PAN AMERICAN HEALTH ORGANIZATION (PAHO) | ||||||||
| 525 TWENTY-THIRD STREET NW | WASHINGTON | DC | 20037 | 237072046 | 501(C)(3) | $50,000 | PRODUCT DEVELOPMENT | |
| PHARMAJET INC | ||||||||
| 400 CORPORATE CIRCLE | GOLDEN | CO | 80401 | 203058403 | N/A | $200,000 | PRODUCT DEVELOPMENT | |
| POPULATION SERVICES INTERNATIONAL (PSI) | ||||||||
| 1120 19TH STREET NW SUITE 600 | WASHINGTON | DC | 20036 | 560942853 | 501(C)(3) | $39,790 | PRODUCT DEVELOPMENT | |
| POPULATION SERVICES INTERNATIONAL (PSI) | ||||||||
| 1120 19TH STREET NW SUITE 600 | WASHINGTON | DC | 20036 | 560942853 | 501(C)(3) | $18,699 | PRODUCT DEVELOPMENT | |
| PRICE CONSULTING LLC | ||||||||
| 2617 BOYER AVE E | SEATTLE | WA | 98121 | 462513741 | N/A | $6,090 | PRODUCT DEVELOPMENT | |
| PUBLIC HEALTH INSTITUTE | ||||||||
| 555 12TH STREET 10TH FLOOR | OAKLAND | CA | 946074046 | 941646278 | 501(C)(3) | $427,336 | PRODUCT DEVELOPMENT | |
| RAINIER CLINICAL RESEARCH CENTER INC | ||||||||
| 723 SW 10TH STREET STE 100 | RENTON | WA | 98057 | 911565985 | N/A | $18,155 | PRODUCT DEVELOPMENT | |
| SABIN VACCINE INSTITUTE | ||||||||
| 2000 PENNSYLVANIA AVENUE SUITE 7100 | WASHINGTON | DC | 20036 | 061389829 | 501(C)(3) | $100,000 | PRODUCT DEVELOPMENT | 7100 |
| SANARIA INC | ||||||||
| 9800 MEDICAL CENTER DR A209 | ROCKVILLE | MD | 20850 | 562354362 | N/A | $1,400,000 | PRODUCT DEVELOPMENT | |
| SANARIA INC | ||||||||
| 9800 MEDICAL CENTER DR A209 | ROCKVILLE | MD | 20850 | 562354362 | N/A | $295,000 | PRODUCT DEVELOPMENT | |
| SANARIA INC | ||||||||
| 9800 MEDICAL CENTER DR A209 | ROCKVILLE | MD | 20850 | 562354362 | N/A | $160,000 | PRODUCT DEVELOPMENT | |
| SAVE THE CHILDREN | ||||||||
| 501 KINGS HWY E | FAIRFIELD | CT | 068254861 | 060726487 | 501(C)(3) | $27,000 | PRODUCT DEVELOPMENT | |
| SEATTLE BIOMEDICAL RESEARCH INSTITUTE | ||||||||
| 307 WESTLAKE AVE N SUITE 500 | SEATTLE | WA | 981095219 | 910961784 | 501(C)(3) | $64,236 | PRODUCT DEVELOPMENT | |
| SEATTLE BIOMEDICAL RESEARCH INSTITUTE (SBRI) | ||||||||
| 307 WESTLAKE AVE N SUITE 500 | SEATTLE | WA | 981095219 | 910961784 | 501(C)(3) | $55,007 | PRODUCT DEVELOPMENT | |
| SEATTLE BIOMEDICAL RESEARCH INSTITUTE (SBRI) | ||||||||
| 307 WESTLAKE AVE N SUITE 500 | SEATTLE | WA | 981095219 | 910961784 | 501(C)(3) | $145,000 | PRODUCT DEVELOPMENT | |
| SYMBIENT PRODUCT DEVELOPMENT | ||||||||
| 1061 LA MIRADA CT | VISTA | CA | 981095219 | 200857602 | N/A | $14,064 | PRODUCT DEVELOPMENT | |
| THE POPULATION COUNCIL | ||||||||
| ONE DAG HAMMARSKJOLD PLAZA 9TH | NEW YORK | NY | 10017 | 520595110 | 501(C)(3) | $1,024,439 | PRODUCT DEVELOPMENT | FLOOR |
| US NAVAL MEDICAL RESEARCH CENTER (NMRC) | ||||||||
| 503 ROBERT GRANT AVE | SILVER SPRING | MD | 209107500 | 470100048 | GOVERNMENT | $400,000 | PRODUCT DEVELOPMENT | |
| US NAVAL MEDICAL RESEARCH CENTER (NMRC) | ||||||||
| 503 ROBERT GRANT AVE | SILVER SPRING | MD | 209107500 | 470100048 | GOVERNMENT | $300,000 | PRODUCT DEVELOPMENT | |
| US NAVAL MEDICAL RESEARCH CENTER (NMRC) | ||||||||
| 503 ROBERT GRANT AVE | SILVER SPRING | MD | 209107500 | 470100048 | GOVERNMENT | $180,863 | PRODUCT DEVELOPMENT | |
| UNIVERSITY OF FLORIDA | ||||||||
| 219 GRINTER HALL PO BOX 115500 | GAINESVILLE | FL | 326115500 | 596002052 | 501(C)(3) | $60,000 | PRODUCT DEVELOPMENT | |
| UNIVERSITY OF KANSAS CENTER FOR RESEARCH INC | ||||||||
| 2385 IRVING HILL ROAD | LAWRENCE | KS | 66045 | 480680117 | 501(C)(3) | $110,000 | PRODUCT DEVELOPMENT | |
| UNIVERSITY OF KANSAS CENTER FOR RESEARCH INC | ||||||||
| 2385 IRVING HILL ROAD | LAWRENCE | KS | 66045 | 480680117 | 501(C)(3) | $6,000 | PRODUCT DEVELOPMENT | |
| UNIVERSITY OF MARYLAND BALTIMORE | ||||||||
| PO BOX 41428 | BALTIMORE | MD | 212036428 | 526002033 | GOVERNMENT | $600,000 | PRODUCT DEVELOPMENT | |
| UNIVERSITY OF MIAMI | ||||||||
| 1320 SOUTH DIXIE HIGHWAY GABLES ONE | CORAL GABLES | FL | 33146 | 590624458 | 501(C)(3) | $12,496 | PRODUCT DEVELOPMENT | TOWER SUITE 650 |
| UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | ||||||||
| 720 MARTIN LUTHER KING JR BLVD | CHAPEL HILL | NC | 275993368 | 566001393 | 501(C)(3) | $46,566 | PRODUCT DEVELOPMENT | SUITE |
| UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | ||||||||
| 720 MARTIN LUTHER KING JR BLVD | CHAPEL HILL | NC | 275993368 | 566001393 | 501(C)(3) | $12,812 | PRODUCT DEVELOPMENT | SUITE |
| UNIVERSITY OF WASHINGTON | ||||||||
| 4333 BROOKLYN AVE NE BOX 359472 | SEATTLE | WA | 98195 | 916001537 | 501(C)(3) | $138,384 | PRODUCT DEVELOPMENT | |
| UNIVERSITY OF WASHINGTON | ||||||||
| 4333 BROOKLYN AVE NE BOX 359472 | SEATTLE | WA | 98195 | 916001537 | 501(C)(3) | $46,303 | PRODUCT DEVELOPMENT | |
| UNIVERSITY OF WASHINGTON | ||||||||
| 4333 BROOKLYN AVE NE BOX 359472 | SEATTLE | WA | 98195 | 916001537 | 501(C)(3) | $17,414 | PRODUCT DEVELOPMENT | |
| UNIVERSITY OF WASHINGTON | ||||||||
| 4333 BROOKLYN AVE NE BOX 359472 | SEATTLE | WA | 98195 | 916001537 | 501(C)(3) | $17,846 | PRODUCT DEVELOPMENT | |
| UNIVERSITY OF WASHINGTON | ||||||||
| 4333 BROOKLYN AVE NE BOX 359472 | SEATTLE | WA | 98195 | 916001537 | 501(C)(3) | $5,996 | PRODUCT DEVELOPMENT | |
| VAXESS TECHNOLOGIES INC | ||||||||
| 125 WESTERN AVENUE | ALLSTON | MA | 02134 | 460612554 | N/A | $8,071 | PRODUCT DEVELOPMENT | |
| VENTURE STRATEGIES INNOVATIONS | ||||||||
| 19200 VON KARMAN AVENUE SUITE 400 | IRVINE | CA | 92612 | 262813021 | 501(C)(3) | $90,084 | PRODUCT DEVELOPMENT | |
| VILLAGEREACH | ||||||||
| 601 NORTH 34TH STREET | SEATTLE | WA | 98103 | 912082484 | 501(C)(3) | $182,739 | PRODUCT DEVELOPMENT | |
| VILLAGEREACH | ||||||||
| 601 NORTH 34TH STREET | SEATTLE | WA | 98103 | 912082484 | 501(C)(3) | $55,000 | PRODUCT DEVELOPMENT | |
| VILLAGEREACH | ||||||||
| 601 NORTH 34TH STREET | SEATTLE | WA | 98103 | 912082484 | 501(C)(3) | $16,000 | PRODUCT DEVELOPMENT | |
| WALTER REED ARMY INSTITUTE OF RESEARCH (WRAIR) | ||||||||
| 503 ROBERT GRANT DRIVE | SILVER SPRING | MD | 20910 | 520664528 | GOVERNMENT | $902,250 | PRODUCT DEVELOPMENT | |
| WALTER REED ARMY INSTITUTE OF RESEARCH (WRAIR) | ||||||||
| 503 ROBERT GRANT DRIVE | SILVER SPRING | MD | 20910 | 520664528 | GOVERNMENT | $449,966 | PRODUCT DEVELOPMENT | |
| WALTER REED ARMY INSTITUTE OF RESEARCH (WRAIR) | ||||||||
| 503 ROBERT GRANT DRIVE | SILVER SPRING | MD | 20910 | 520664528 | GOVERNMENT | $198,508 | PRODUCT DEVELOPMENT | |
| WALTER REED ARMY INSTITUTE OF RESEARCH (WRAIR) | ||||||||
| 503 ROBERT GRANT DRIVE | SILVER SPRING | MD | 20910 | 520664528 | GOVERNMENT | $172,063 | PRODUCT DEVELOPMENT | |
| WALTER REED ARMY INSTITUTE OF RESEARCH (WRAIR) | ||||||||
| 503 ROBERT GRANT DRIVE | SILVER SPRING | MD | 20910 | 520664528 | GOVERNMENT | $53,739 | PRODUCT DEVELOPMENT | |
| YALE UNIVERSITY | ||||||||
| 310 CEDAR STREET | NEW HAVEN | CT | 06510 | 060646973 | 501(C)(3) | $472,421 | PRODUCT DEVELOPMENT | |
| DALBERG CONSULTING US LLC | ||||||||
| 99 MADISON AVENUE 17TH FLOOR | NEW YORK | NY | 10016 | 261546220 | N/A | $181,081 | PUBLIC HEALTH IMPACT | |
| EMORY UNIVERSITY | ||||||||
| 1599 CLIFTON RD NE 4TH FLOOR | ATLANTA | GA | 303224250 | 580566256 | 501(C)(3) | $807,288 | PUBLIC HEALTH IMPACT | MAILSTOP 1499/001/1BH |
| FAMILY HEALTH INTERNATIONAL (FHI) 360 | ||||||||
| PO BOX 13950 2224 E NC HWY 54 | DURHAM | NC | 27713 | 237413005 | 501(C)(3) | $158,739 | PUBLIC HEALTH IMPACT | |
| FAMILY HEALTH INTERNATIONAL (FHI) 360 | ||||||||
| PO BOX 13950 2224 E NC HWY 54 | DURHAM | NC | 27713 | 237413005 | 501(C)(3) | $101,460 | PUBLIC HEALTH IMPACT | |
| FINANCING FOR DEVELOPMENT | ||||||||
| 1800 MASSACHUSETTS AVENUE SUITE 400 | WASHINGTON | DC | 20036 | 680683026 | 501(C)(3) | $370,000 | PUBLIC HEALTH IMPACT | 400 |
| FINANCING FOR DEVELOPMENT | ||||||||
| 1800 MASSACHUSETTS AVENUE SUITE 400 | WASHINGTON | DC | 20036 | 680683026 | 501(C)(3) | $91,565 | PUBLIC HEALTH IMPACT | 400 |
| GREENEWORKS GLOBAL LLC | ||||||||
| 3733 WARREN STREET NW | WASHINGTON | DC | 20016 | 800672849 | N/A | $25,000 | PUBLIC HEALTH IMPACT | |
| JOHN SNOW INC (JSI) | ||||||||
| 44 FARNSWORTH STREET | BOSTON | MA | 02210 | 042578580 | N/A | $5,000 | PUBLIC HEALTH IMPACT | |
| JOHNS HOPKINS UNIVERSITY (JHU) | ||||||||
| 3400 N CHARLES ST | BALTIMORE | MD | 21218 | 131687001 | 501(C)(3) | $121,783 | PUBLIC HEALTH IMPACT | |
| KANSAS STATE UNIVERSITY | ||||||||
| COLLEGE OF VETERINARY MEDICINE | MANHATTAN | KS | 665065601 | 480771751 | 501(C)(3) | $12,300 | PUBLIC HEALTH IMPACT | |
| KYBELE INC | ||||||||
| 3524 YADKINVILLE ROAD 124 | WINSTON SALEM | NC | 27106 | 900759003 | 501(C)(3) | $132,122 | PUBLIC HEALTH IMPACT | |
| POPULATION ACTION INTERNATIONAL | ||||||||
| 1300 19TH STREET NW | WASHINGTON | DC | 20036 | 520812075 | 501(C)(3) | $36,518 | PUBLIC HEALTH IMPACT | |
| THE POPULATION COUNCIL | ||||||||
| ONE DAG HAMMARSKJOLD PLAZA 9TH | NEW YORK | NY | 10017 | 520595110 | 501(C)(3) | $771,119 | PUBLIC HEALTH IMPACT | FLOOR |
| US PHARMACOPEIAL CONVENTION | ||||||||
| USP HEADQUARTERS 12601 TWIN BROOK | ROCKVILLE | MD | 208521790 | 131656692 | 501(C)(3) | $25,000 | PUBLIC HEALTH IMPACT | PARKWAY |
| WORLD VISION INC | ||||||||
| P O BOX 9716 DEPT W | FEDERAL WAY | WA | 980639716 | 951922279 | 501(C)(3) | $19,472 | PUBLIC HEALTH IMPACT | |
| PROFECTUS BIOSCIENCES INC | ||||||||
| 6411 BECKLEY ST | BALTIMORE | MD | 21224 | 020579416 | N/A | -$29,030 | PRODUCT DEVELOPMENT | |
| SEATTLE BIOMEDICAL RESEARCH INSTITUTE | ||||||||
| 307 WESTLAKE AVE N 500 | SEATTLE | WA | 98109 | 910961784 | 501(C)(3) | -$30,339 | PRODUCT DEVELOPMENT | |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 51 | Total501c3OrgCnt |
| Total Other Org | 18 | TotalOtherOrgCnt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 2: | FormAndLineReferenceDesc |
| Explanation | SUBRECIPIENTS ARE REQUIRED TO SUBMIT PROGRESS REPORTS, WHICH ARE REVIEWED BY RESPONSIBLE PATH PROGRAM MANAGERS AND PROGRAM ADMINISTRATORS TO ENSURE THAT PROGRAM GOALS ARE ATTAINED IN ACCORDANCE WITH AGREEMENT REQUIREMENTS. THE RESPONSIBLE PROGRAM MANAGERS AND PROGRAM ADMINISTRATORS CONTACT SUBRECIPIENTS WITH QUESTIONS AND FOLLOW UP ON ANY CONCERNS. IN SOME CASES, SUBAWARD TERMS MAY REQUIRE SPECIFIED DELIVERABLES IN ADDITION TO, OR IN LIEU OF, TECHNICAL REPORTS. IN ADDITION, DISCRETIONARY ON-SITE VISITS ARE CONDUCTED TO EVALUATE BOTH COMPLIANCE WITH THE SCIENTIFIC OBJECTIVES OF THE PROJECT AND THE APPROPRIATENESS OF THE SUBRECIPIENT'S ADMINISTRATIVE SYSTEMS AND PROCESSES. PATH ALSO USES CROSS-PROGRAM INDICATORS TO TRACK OVERALL ORGANIZATIONAL PERFORMANCE AND LINK OUR WORK AND THE WORK OF SUBRECIPIENTS TO SPECIFIC IMPROVEMENTS IN HEALTH-RELATED OUTCOMES. MONITORING THIS SET OF INDICATORS HELPS PATH SET BENCHMARKS AND ADOPT BEST PRACTICES THAT IMPROVE PROGRAMMATIC EFFECTIVENESS OVER TIME. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Idemnification Gross Up Pmts | Yes (X) | IdemnificationGrossUpPmtsInd |
| Housing Allowance Or Residence | Yes (X) | HousingAllowanceOrResidenceInd |
| Written Policy Ref T And E Expnss | Yes (1) | WrittenPolicyRefTAndEExpnssInd |
| Substantiation Required | Yes (1) | SubstantiationRequiredInd |
| Compensation Committee | Yes (X) | CompensationCommitteeInd |
| Independent Consultant | Yes (X) | IndependentConsultantInd |
| Compensation Survey | Yes (X) | CompensationSurveyInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | Yes (1) | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | 0 | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | 0 | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | 0 | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | 0 | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | 0 | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | 0 | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | Yes (1) | AnyNonFixedPaymentsInd |
| Initial Contract Exception | 0 | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (28 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| STEVEN B DAVIS | ||||||||||||||
| PRESIDENT AND CEO | $420,801 | $0 | $59,938 | $0 | $500 | $0 | $30,600 | $0 | $11,028 | $0 | $522,867 | $0 | $0 | $0 |
| ERIC G WALKER | ||||||||||||||
| VP, CORPORATE SVC. (UNTIL 10/2/2013) | $351,054 | $0 | $0 | $0 | $1,000 | $0 | $25,448 | $0 | $9,163 | $0 | $386,665 | $0 | $0 | $0 |
| MICHAEL B KOLLINS | ||||||||||||||
| COO (BEGAN 5/31/2013) | $138,498 | $0 | $0 | $0 | $1,769 | $0 | $6,417 | $0 | $6,433 | $0 | $153,117 | $0 | $0 | $0 |
| DAVID C KASLOW | ||||||||||||||
| VP, PRODUCT DEV. (BEGAN 10/1/2013) | $322,388 | $0 | $0 | $0 | $75 | $0 | $28,491 | $0 | $11,028 | $0 | $361,982 | $0 | $0 | $0 |
| AYORINDE ARNOLD AJAYI | ||||||||||||||
| VP, INTERNATIONAL DEVELOPMENT | $256,904 | $0 | $0 | $0 | $0 | $0 | $28,482 | $0 | $6,256 | $0 | $291,642 | $0 | $0 | $0 |
| SARAH C TEMPLE | ||||||||||||||
| VP, EXTERNAL RELATIONS | $225,325 | $0 | $0 | $0 | $770 | $0 | $27,031 | $0 | $8,880 | $0 | $262,006 | $0 | $0 | $0 |
| DAN LASTER | ||||||||||||||
| GENERAL COUNSEL | $224,390 | $0 | $0 | $0 | $770 | $0 | $24,497 | $0 | $11,001 | $0 | $260,658 | $0 | $0 | $0 |
| JACQUELINE D SHERRIS | ||||||||||||||
| VP, PUBLIC HEALTH IMPACT | $208,637 | $0 | $0 | $0 | $244 | $0 | $24,564 | $0 | $2,876 | $0 | $236,321 | $0 | $0 | $0 |
| KATHRYN A O'DRISCOLL | ||||||||||||||
| CHIEF HUMAN RESOURCES OFFICER | $206,023 | $0 | $0 | $0 | $770 | $0 | $24,696 | $0 | $10,934 | $0 | $242,423 | $0 | $0 | $0 |
| AMIE E BATSON | ||||||||||||||
| CHIEF STRATEGY OFF. (BEGAN 4/8/13) | $178,128 | $0 | $15,000 | $0 | $0 | $0 | $9,625 | $0 | $954 | $0 | $203,707 | $0 | $0 | $0 |
| JOHN W BOSLEGO | ||||||||||||||
| DIRECTOR, VACCINE DEV. GLOBAL PROG. | $319,488 | $0 | $0 | $0 | $0 | $0 | $30,600 | $0 | $9,390 | $0 | $359,478 | $0 | $0 | $0 |
| PAWANA WIENRAWEE | ||||||||||||||
| DIRECTOR, THAILAND PROGRAMS | $127,093 | $0 | $0 | $0 | $157,261 | $0 | $15,251 | $0 | $8,753 | $0 | $308,358 | $0 | $0 | $0 |
| PONNI SUBBIAH | ||||||||||||||
| DIRECTOR, DRUG DEVELOPMENT | $276,446 | $0 | $0 | $0 | $770 | $0 | $21,547 | $0 | $9,787 | $0 | $308,550 | $0 | $0 | $0 |
| RIKKA E TRANGSRUD | ||||||||||||||
| COUNTRY PROGRAM LEADER, KENYA | $169,524 | $0 | $0 | $0 | $106,132 | $0 | $19,210 | $0 | $9,773 | $0 | $304,639 | $0 | $0 | $0 |
| TRAD M HATTON | ||||||||||||||
| CHIEF OF PARTY, INTEGRATED HIV/AIDS | $167,929 | $0 | $0 | $0 | $97,468 | $0 | $14,031 | $0 | $10,065 | $0 | $289,493 | $0 | $0 | $0 |
| CARLOS CLINTON CAMPBELL | ||||||||||||||
| DIRECTOR, MALARIA CONTROL PROGRAM | $249,335 | $0 | $0 | $0 | $5,339 | $0 | $25,332 | $0 | $2,531 | $0 | $282,537 | $0 | $0 | $0 |
| ANURAG PRABHAKAR MAIRAL | ||||||||||||||
| DIRECTOR, TECHNOLOGY SOLUTIONS | $214,170 | $0 | $25,000 | $0 | $15,280 | $0 | $16,150 | $0 | $8,892 | $0 | $279,492 | $0 | $0 | $0 |
| ASHLEY BIRKETT | ||||||||||||||
| DIRECTOR, RESEARCH AND DEVELOPMENT | $239,169 | $0 | $0 | $0 | $6,096 | $0 | $26,189 | $0 | $11,026 | $0 | $282,480 | $0 | $0 | $0 |
| RAMONA ANNE BYRKIT | ||||||||||||||
| COUNTRY PROGRAM LEADER, VIETNAM | $160,685 | $0 | $0 | $0 | $82,164 | $0 | $19,220 | $0 | $10,202 | $0 | $272,271 | $0 | $0 | $0 |
| KATHLEEN M NEUZIL | ||||||||||||||
| GLOBAL PROGRAM LEADER, VAD | $234,320 | $0 | $0 | $0 | $0 | $0 | $24,962 | $0 | $9,958 | $0 | $269,240 | $0 | $0 | $0 |
| CATHARINE HOWARD TAYLOR | ||||||||||||||
| GLOBAL PROGRAM LEADER, MCHN | $210,119 | $0 | $0 | $0 | $0 | $0 | $25,214 | $0 | $7,689 | $0 | $243,022 | $0 | $0 | $0 |
| JANE E HUTCHINGS | ||||||||||||||
| DIRECTOR, REPRODUCTIVE HEALTH | $198,328 | $0 | $0 | $0 | $0 | $0 | $23,115 | $0 | $10,881 | $0 | $232,324 | $0 | $0 | $0 |
| RACHEL WILSON | ||||||||||||||
| SENIOR DIRECTOR, POLICY & ADVOCACY | $190,167 | $0 | $0 | $0 | $75 | $0 | $22,812 | $0 | $9,345 | $0 | $222,399 | $0 | $0 | $0 |
| JOHN SKIBIAK | ||||||||||||||
| DIRECTOR, RHSC | $190,662 | $0 | $0 | $0 | $76,887 | $0 | $22,824 | $0 | $10,279 | $0 | $300,652 | $0 | $0 | $0 |
| JEAN A NTUMBA BIDUAYA | ||||||||||||||
| FIN. & ADMIN. SPECIALIST, HIV & TB | $81,509 | $0 | $0 | $0 | $168,173 | $0 | $8,933 | $0 | $9,967 | $0 | $268,582 | $0 | $0 | $0 |
| DUNCAN OWENS EARLE | ||||||||||||||
| PROG. DIR., MALARIA CONTROL & EVAL. | $210,890 | $0 | $0 | $0 | $32,700 | $0 | $25,307 | $0 | $5,544 | $0 | $274,441 | $0 | $0 | $0 |
| BONIFACE MUTOMBO WA MUTOMBO | ||||||||||||||
| SENIOR PROGRAM OFFICER | $133,860 | $0 | $0 | $0 | $106,428 | $0 | $16,063 | $0 | $8,785 | $0 | $265,136 | $0 | $0 | $0 |
| GEORGE A ROBERTSON | ||||||||||||||
| SENIOR TECHNICAL ADVISOR | $228,411 | $0 | $0 | $0 | $0 | $0 | $27,409 | $0 | $10,944 | $0 | $266,764 | $0 | $0 | $0 |
Supplemental Information Detail SupplementalInformationDetail (3 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART I, LINE 1A | HOUSING ALLOWANCE & TAX INDEMNIFICATION ARE ONLY PROVIDED TO THOSE INDIVIDUALS WHO ARE EXPATRIATE EMPLOYEES. ALL BENEFIT PAYMENTS ARE MADE ACCORDING TO OUR EXPATRIATE POLICY. PART I, LINE 3: PATH ENGAGES WITH A CONSULTING FIRM TO REVIEW THE COMPENSATION FOR EACH OF THE SENIOR MANAGEMENT POSITION. PATH PROVIDES AN ANNUAL SALARY ADJUSTMENT EACH JANUARY BASED ON THE OVERALL LABOR MARKET MOVEMENT. |
| PART I, LINE 4A | SEVERANCE WAS PAID TO BONIFACE MUTOMBO WA MUTOMBO ($42,180) AND PAWANA WIENRAWEE ($156,115). |
| PART I, LINE 7 | BONUS COMPENSATION HAS BEEN REFLECTED IN PART II, COLUMN (B)(II). |
Schedule M IRS990ScheduleM
Securities Publicly Traded SecuritiesPubliclyTradedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | Yes (X) | NonCashCheckboxInd |
| Contribution | 17 | ContributionCnt |
| Noncash Contributions Rpt F990 | $81,103 | NoncashContributionsRptF990Amt |
| Method Of Determining Revenues | FMV | MethodOfDeterminingRevenuesTxt |
Other Non Cash Contri Table OtherNonCashContriTableGrp (3 entries)
| Non Cash CheckboxNonCashCheckboxInd | DescDesc | ContributionContributionCnt | Noncash Contributions Rpt F990NoncashContributionsRptF990Amt | Method Of Determining RevenuesMethodOfDeterminingRevenuesTxt |
|---|---|---|---|---|
| Yes (X) | SUPPLIES | 5 | $24,759 | COST OR SALES PRICE |
| Yes (X) | EQUIPMENT | 1 | $1,245 | COST OR SALES PRICE |
| Yes (X) | SOFTWARE | 1 | $379 | COST OR SALES PRICE |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form8283 Received | 0 | Form8283ReceivedCnt |
| Any Property That Must Be Held | 0 | AnyPropertyThatMustBeHeldInd |
| Review Process Unusual NC Gifts | Yes (1) | ReviewProcessUnusualNCGiftsInd |
| Third Parties Used | 0 | ThirdPartiesUsedInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, COLUMN (B): | FormAndLineReferenceDesc |
| Explanation | THIS COLUMN REFLECTS THE NUMBER OF CONTRIBUTIONS. | ExplanationTxt |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (4 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| FORM 990, PART VI, SECTION B, LINE 11 | THE FORM 990 WAS PREPARED BY THE OUTSIDE ACCOUNTING FIRM USING INFORMATION PROVIDED BY PATH ACCOUNTING SERVICES STAFF. PATH SENIOR MANAGEMENT REVIEWED THE DRAFT FORM. A COPY OF THE FINAL 990 WAS SENT TO THE BOARD OF DIRECTORS FOR COMMENT. AFTER THE COMMENT PERIOD, THE CFO SIGNED THE RETURN. |
| FORM 990, PART VI, SECTION B, LINE 12C | BOARD MEMBERS, PATH MANAGEMENT, AND ALL STAFF ABOVE A DESIGNATED LEVEL IN THE ORGANIZATION MUST COMPLETE A CONFLICT OF INTEREST DISCLOSURE FORM EACH YEAR. ALL FORMS ARE REVIEWED AND KEPT ON FILE. A CONFLICT MANAGEMENT PLAN IS DEVELOPED FOR ANY EMPLOYEE WITH A SIGNIFICANT ACTUAL OR PERCEIVED CONFLICT OF INTEREST. |
| FORM 990, PART VI, SECTION B, LINE 15 | THE BOARD'S COMPENSATION COMMITTEE ANNUALLY REVIEWS SALARY AND BENEFITS FOR KEY EMPLOYEE POSITIONS AND PROVIDES GUIDANCE TO THE CEO ON COMPENSATION DECISIONS FOR KEY POSITIONS. THE COMPENSATION AND BENEFITS FOR PATH'S PRESIDENT AND CEO ARE REVIEWED AND APPROVED BY THE ENTIRE BOARD OF DIRECTORS EACH YEAR AT THE MAY BOARD MEETING. PATH ROUTINELY USES THE SERVICES OF EXTERNAL FIRMS TO ASSESS AND BENCHMARK EXECUTIVE COMPENSATION (PRESIDENT/CEO AND VICE PRESIDENTS). THE LAST MAJOR REVIEW WAS COMPLETED IN 2014, WHEN PATH ENGAGED MERCER (A COMPENSATION, BENEFITS, AND HUMAN RESOURCES CONSULTING FIRM) TO REVIEW CURRENT AND PROPOSED BASE SALARIES OF PATH'S PRESIDENT/CEO, VICE PRESIDENTS, AND PROGRAM/DEPARTMENT LEADERS. MERCER USED DATA FROM MULTIPLE SOURCES TO EVALUATE CURRENT AND PROPOSED BASE SALARIES FOR THESE POSITIONS. THE BOARD'S COMPENSATION COMMITTEE REVIEWED THE MERCER REPORT AND APPROVED THE COMPENSATION PACKAGES FOR THE VICE PRESIDENTS, WITH RATIFICATION BY THE BOARD. THE BOARD ALSO APPROVED THE COMMITTEE'S RECOMMENDATION FOR THE PRESIDENT/CEO'S COMPENSATION. ADDITIONALLY, MERCER REVIEWED THE PROPOSED TOTAL COMPENSATION AND BENEFIT PACKAGE FOR THE PRESIDENT/CEO POSITION AND OBTAINED A SIGNIFICANT NUMBER OF DATA POINTS TO ASCERTAIN ITS REASONABLENESS AND APPROPRIATENESS. THE BOARD REVIEWED MERCER'S FINDINGS AND APPROVED THE TOTAL PACKAGE FOR THIS POSITION. |
| FORM 990, PART VI, SECTION C, LINE 19 | PATH MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. |
Schedule R IRS990ScheduleR
Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (4 entries)
| Address Line1USAddress/AddressLine1 | CityUSAddress/City | StateUSAddress/State | ZIP CodeUSAddress/ZIPCode | EINEIN | Primary ActivitiesPrimaryActivitiesTxt | Legal Domicile StateLegalDomicileStateCd | Exempt Code SectionExemptCodeSectionTxt | Public Charity StatusPublicCharityStatusTxt | Business Name Line1DirectControllingEntityName/BusinessNameLine1 | Controlled OrganizationControlledOrganizationInd | Address Line1ForeignAddress/AddressLine1 | CityForeignAddress/City | CountryForeignAddress/Country | Legal Domicile Foreign CountryLegalDomicileForeignCountryCd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PATH VACCINE SOLUTIONS | ||||||||||||||
| 2201 WESTLAKE AVENUE | SEATTLE | WA | 98109 | 830431851 | ADVANCE DEVELOPMENT OF VACCINES TO IMPROVE THE HEALTH OF CHILDREN | WA | 501(C)(3) | LINE 11A | PATH | Yes (1) | ||||
| ORGANIZATION FOR APPROPRIATE TECHNOLOGY IN HEALTH | ||||||||||||||
| REDUCE THE TB BURDEN IN UKRAINE | N/A | N/A | PATH | Yes (1) | 25 BUILDING B0 SHOTA RUSTAVELI STR | KYIV | UP | UP | ||||||
| PATH DRUG SOLUTIONS | ||||||||||||||
| 280 UTAH AVENUE SUITE 250 | SAN FRANCISCO | CA | 94080 | 943384500 | DEVELOPMENT & DISTRIBUTION OF SAFE, EFFECTIVE, AND AFFORDABLE MEDICINES | CA | 501(C)(3) | LINE 11A | PATH | Yes (1) | ||||
| FOUNDATION FOR APPROPRIATE TECHNOLOGIES IN HEALTH - SWITZERLAND | ||||||||||||||
| EDUCATIONAL AND SCIENTIFIC PROMOTION OF HEALTH | N/A | N/A | PATH | Yes (1) | 207 ROUTE DE FERNEY 1218 LE GRAND-S | GENEVA | SZ | SZ | ||||||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Receipt Of Int Annts Rnts Rylts | 0 | ReceiptOfIntAnntsRntsRyltsInd |
| Gift Grnt Or Cap Contri To Oth Org | Yes (1) | GiftGrntOrCapContriToOthOrgInd |
| Gift Grnt Cap Contri From Oth Org | Yes (1) | GiftGrntCapContriFromOthOrgInd |
| Loans Or Guarantees To Other Org | 0 | LoansOrGuaranteesToOtherOrgInd |
| Loans Or Guarantees From Oth Org | 0 | LoansOrGuaranteesFromOthOrgInd |
| Div Related Organization | 0 | DivRelatedOrganizationInd |
| Asset Sale To Other Org | 0 | AssetSaleToOtherOrgInd |
| Asset Purchase From Other Org | 0 | AssetPurchaseFromOtherOrgInd |
| Asset Exchange | 0 | AssetExchangeInd |
| Rental Of Facilities To Oth Org | 0 | RentalOfFacilitiesToOthOrgInd |
| Rental Of Fclts From Oth Org | 0 | RentalOfFcltsFromOthOrgInd |
| Perform Of Services For Oth Org | 0 | PerformOfServicesForOthOrgInd |
| Perform Of Services By Other Org | 0 | PerformOfServicesByOtherOrgInd |
| Sharing Of Facilities | 0 | SharingOfFacilitiesInd |
| Paid Employees Sharing | 0 | PaidEmployeesSharingInd |
| Reimbursement Paid To Other Org | 0 | ReimbursementPaidToOtherOrgInd |
| Reimbursement Paid By Other Org | 0 | ReimbursementPaidByOtherOrgInd |
| Transfer To Other Org | 0 | TransferToOtherOrgInd |
| Transfer From Other Org | 0 | TransferFromOtherOrgInd |
Transactions Related Org TransactionsRelatedOrgGrp (8 entries)
| Transaction TypeTransactionTypeTxt | InvolvedInvolvedAmt | Method Of Amount DeterminationMethodOfAmountDeterminationTxt |
|---|---|---|
| PATH VACCINE SOLUTIONS | ||
| C | $12,702,315 | FMV |
| PATH VACCINE SOLUTIONS | ||
| B | $424,773 | FMV |
| ORGANIZATION FOR APPROPRIATE TECHNOLOGY IN HEALTH | ||
| C | $423,280 | FMV |
| ORGANIZATION FOR APPROPRIATE TECHNOLOGY IN HEALTH | ||
| B | $919,588 | FMV |
| PATH DRUG SOLUTIONS | ||
| C | $4,022,391 | FMV |
| PATH DRUG SOLUTIONS | ||
| B | $535,489 | FMV |
| FOUNDATION FOR APPROPRIATE TECHNOLOGIES IN HEALTH - SWITZERLAND | ||
| C | $1,325,097 | FMV |
| FOUNDATION FOR APPROPRIATE TECHNOLOGIES IN HEALTH - SWITZERLAND | ||
| B | $3,352,920 | FMV |
Comments